ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME

Information

  • Patent Application
  • 20230301175
  • Publication Number
    20230301175
  • Date Filed
    December 23, 2020
    4 years ago
  • Date Published
    September 21, 2023
    a year ago
Abstract
The present disclosure relates to an OLED that includes a first electrode; a second electrode facing the first electrode; a first emitting material layer including a first host being an anthracene derivative and a first dopant being a pyrene derivative and positioned between the first and second electrodes; and a first electron blocking layer including an electron blocking material of a spirofluorene-substituted amine derivative and positioned between the first electrode and the first emitting material layer, wherein at least one of hydrogen atoms in the anthracene derivative and the pyrene derivative is deuterated.
Description
TECHNICAL FIELD

The present disclosure relates to an organic light emitting diode (OLED), and more specifically, to an OLED having enhanced emitting efficiency and lifespan and an organic light emitting device including the same.


Background Art

As requests for a flat panel display device having a small occupied area have been increased, an organic light emitting display device including an OLED has been research and development.


The OLED emits light by injecting electrons from a cathode as an electron injection electrode and holes from an anode as a hole injection electrode into an emitting material layer (EML), combining the electrons with the holes, generating an exciton, and transforming the exciton from an excited state to a ground state. A flexible substrate, for example, a plastic substrate, can be used as a base substrate where elements are formed. In addition, the organic light emitting display device can be operated at a voltage (e.g., 10 V or below) lower than a voltage required to operate other display devices. Moreover, the organic light emitting display device has advantages in the power consumption and the color sense.


The OLED includes a first electrode as an anode over a substrate, a second electrode, which is spaced apart from and faces the first electrode, and an organic emitting layer therebetween.


For example, the organic light emitting display device may include a red pixel region, a green pixel region and a blue pixel region, and the OLED may be formed in each of the red, green and blue pixel regions.


However, the OLED in the blue pixel does not provide sufficient emitting efficiency and lifespan such that the organic light emitting display device has a limitation in the emitting efficiency and the lifespan.


Disclosure
[Technical Problem]

Accordingly, the present disclosure is directed to an OLED and an organic light emitting device including the OLED that substantially obviate one or more of the problems due to the limitations and disadvantages of the related art.


An object of the present disclosure is to provide an OLED having enhanced emitting efficiency and lifespan and an organic light emitting device including the same.


Additional features and advantages of the disclosure will be set forth in the description which follows, and in part will be apparent from the description, or may be learned by practice of the disclosure. The objectives and other advantages of the disclosure will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.


[Technical Solution]

According to an aspect, the present disclosure provides an OLED that includes a first electrode; a second electrode facing the first electrode; a first emitting material layer including a first host being an anthracene derivative and a first dopant being a pyrene derivative and positioned between the first and second electrodes; and a first electron blocking layer including an electron blocking material of a spirofluorene-substituted amine derivative and positioned between the first electrode and the first emitting material layer, wherein at least one of hydrogen atoms in the anthracene derivative and the pyrene derivative is deuterated.


As an example, all of the hydrogen atoms in at least one of the anthracene derivative and the pyrene derivative are deuterated.


As an example, at least one of an anthracene core of the anthracene derivative and a pyrene core of the pyrene derivative is deuterated.


The OLED may include a single emitting part or a tandem structure of a multiple emitting parts.


The tandem-structured OLED may emit blue color or white color light.


According to another aspect, the present disclosure provides an organic light emitting device comprising the OLED, as described above.


For example, the organic light emitting device may be an organic light emitting display device or a lightening device.


It is to be understood that both the foregoing general description and the following detailed description are examples and are explanatory and are intended to provide further explanation of the disclosure as claimed.


[Advantageous Effects]

An emitting material layer of an OLED of the present disclosure includes a host of an anthracene derivative and a dopant of a pyrene derivative, and at least one of the anthracene derivative and the pyrene derivative is deuterated. In addition, an electron blocking layer of the OLED of the present disclosure includes an electron blocking material being a spirofluorene-substituted amine derivative. As a result, an emitting efficiency and a lifespan of the OLED and an organic light emitting device including the OLED are improved.


Moreover, a hole blocking layer of the OLED includes at least one of an azine derivative and a benzimidazole derivative as a hole blocking material. Accordingly, the lifespan of the OLED and an organic light emitting device is further improved.


Further, since at least one of an anthracene core of the anthracene derivative and a pyrene core of the pyrene derivative is deuterated, an emitting efficiency and a lifespan of the OLED and an organic light emitting device including the OLED are improved with minimizing production cost increase.





DESCRIPTION OF DRAWINGS

The accompanying drawings, which are included to provide a further understanding of the disclosure, are incorporated in and constitute a part of this specification, illustrate implementations of the disclosure and together with the description serve to explain the principles of embodiments of the disclosure.



FIG. 1 is a schematic circuit diagram illustrating an organic light emitting display device of the present disclosure.



FIG. 2 is a schematic cross-sectional view illustrating an organic light emitting display device according to a first embodiment of the present disclosure.



FIG. 3 is a schematic cross-sectional view illustrating an OLED having a single emitting part for the organic light emitting display device according to the first embodiment of the present disclosure.



FIG. 4 is a schematic cross-sectional view illustrating an OLED having a tandem structure of two emitting parts according to the first embodiment of the present disclosure.



FIG. 5 is a schematic cross-sectional view illustrating an organic light emitting display device according to a second embodiment of the present disclosure.



FIG. 6 is a schematic cross-sectional view illustrating an OLED for the organic light emitting display device according to the second embodiment of the present disclosure.



FIG. 7 is a schematic cross-sectional view illustrating an organic light emitting display device according to a third embodiment of the present disclosure.





MODE FOR INVENTION

Reference will now be made in detail to aspects of the disclosure, examples of which are illustrated in the accompanying drawings.



FIG. 1 is a schematic circuit diagram illustrating an organic light emitting display device of the present disclosure.


As illustrated in FIG. 1, a gate line GL and a data line DL, which cross each other to define a pixel (pixel region) P, and a power line PL are formed in an organic light emitting display device. A switching thin film transistor (TFT) Ts, a driving TFT Td, a storage capacitor Cst and an OLED D are formed in the pixel region P. The pixel region P may include a red pixel, a green pixel and a blue pixel.


The switching thin film transistor Ts is connected to the gate line GL and the data line DL, and the driving thin film transistor Td and the storage capacitor Cst are connected between the switching thin film transistor Ts and the power line PL. The OLED D is connected to the driving thin film transistor Td. When the switching thin film transistor Ts is turned on by the gate signal applied through the gate line GL, the data signal applied through the data line DL is applied a gate electrode of the driving thin film transistor Td and one electrode of the storage capacitor Cst through the switching thin film transistor Ts.


The driving thin film transistor Td is turned on by the data signal applied into the gate electrode so that a current proportional to the data signal is supplied from the power line PL to the OLED D through the driving thin film transistor Td. The OLED D emits light having a luminance proportional to the current flowing through the driving thin film transistor Td. In this case, the storage capacitor Cst is charge with a voltage proportional to the data signal so that the voltage of the gate electrode in the driving thin film transistor Td is kept constant during one frame. Therefore, the organic light emitting display device can display a desired image.



FIG. 2 is a schematic cross-sectional view illustrating an organic light emitting display device according to a first embodiment of the present disclosure.


As illustrated in FIG. 2, the organic light emitting display device 100 includes a substrate 110, a TFT Tr and an OLED D connected to the TFT Tr. For example, the organic light emitting display device 100 may include a red pixel, a green pixel and a blue pixel, and the OLED D may be formed in each of the red, green and blue pixels. Namely, the OLEDs D emitting red light, green light and blue light may be provided in the red, green and blue pixels, respectively.


The substrate 110 may be a glass substrate or a plastic substrate. For example, the substrate 110 may be a polyimide substrate.


A buffer layer 120 is formed on the substrate, and the TFT Tr is formed on the buffer layer 120. The buffer layer 120 may be omitted.


A semiconductor layer 122 is formed on the buffer layer 120. The semiconductor layer 122 may include an oxide semiconductor material or polycrystalline silicon.


When the semiconductor layer 122 includes the oxide semiconductor material, a light-shielding pattern (not shown) may be formed under the semiconductor layer 122. The light to the semiconductor layer 122 is shielded or blocked by the light-shielding pattern such that thermal degradation of the semiconductor layer 122 can be prevented. On the other hand, when the semiconductor layer 122 includes polycrystalline silicon, impurities may be doped into both sides of the semiconductor layer 122.


A gate insulating layer 124 is formed on the semiconductor layer 122. The gate insulating layer 124 may be formed of an inorganic insulating material such as silicon oxide or silicon nitride.


A gate electrode 130, which is formed of a conductive material, e.g., metal, is formed on the gate insulating layer 124 to correspond to a center of the semiconductor layer 122.


In FIG. 2, the gate insulating layer 124 is formed on an entire surface of the substrate 110. Alternatively, the gate insulating layer 124 may be patterned to have the same shape as the gate electrode 130.


An interlayer insulating layer 132, which is formed of an insulating material, is formed on the gate electrode 130. The interlayer insulating layer 132 may be formed of an inorganic insulating material, e.g., silicon oxide or silicon nitride, or an organic insulating material, e.g., benzocyclobutene or photo-acryl.


The interlayer insulating layer 132 includes first and second contact holes 134 and 136 exposing both sides of the semiconductor layer 122. The first and second contact holes 134 and 136 are positioned at both sides of the gate electrode 130 to be spaced apart from the gate electrode 130.


The first and second contact holes 134 and 136 are formed through the gate insulating layer 124. Alternatively, when the gate insulating layer 124 is patterned to have the same shape as the gate electrode 130, the first and second contact holes 134 and 136 is formed only through the interlayer insulating layer 132.


A source electrode 140 and a drain electrode 142, which are formed of a conductive material, e.g., metal, are formed on the interlayer insulating layer 132.


The source electrode 140 and the drain electrode 142 are spaced apart from each other with respect to the gate electrode 130 and respectively contact both sides of the semiconductor layer 122 through the first and second contact holes 134 and 136.


The semiconductor layer 122, the gate electrode 130, the source electrode 140 and the drain electrode 142 constitute the TFT Tr. The TFT Tr serves as a driving element. Namely, the TFT Tr may correspond to the driving TFT Td (of FIG. 1).


In the TFT Tr, the gate electrode 130, the source electrode 140, and the drain electrode 142 are positioned over the semiconductor layer 122. Namely, the TFT Tr has a coplanar structure.


Alternatively, in the TFT Tr, the gate electrode may be positioned under the semiconductor layer, and the source and drain electrodes may be positioned over the semiconductor layer such that the TFT Tr may have an inverted staggered structure. In this instance, the semiconductor layer may include amorphous silicon.


Although not shown, the gate line and the data line cross each other to define the pixel, and the switching TFT is formed to be connected to the gate and data lines. The switching TFT is connected to the TFT Tr as the driving element.


In addition, the power line, which may be formed to be parallel to and spaced apart from one of the gate and data lines, and the storage capacitor for maintaining the voltage of the gate electrode of the TFT Tr in one frame may be further formed.


A passivation layer 150, which includes a drain contact hole 152 exposing the drain electrode 142 of the TFT Tr, is formed to cover the TFT Tr.


A first electrode 160, which is connected to the drain electrode 142 of the TFT Tr through the drain contact hole 152, is separately formed in each pixel. The first electrode 160 may be an anode and may be formed of a conductive material having a relatively high work function. For example, the first electrode 160 may be formed of a transparent conductive material such as indium-tin-oxide (ITO) or indium-zinc-oxide (IZO).


When the OLED device 100 is operated in a top-emission type, a reflection electrode or a reflection layer may be formed under the first electrode 160. For example, the reflection electrode or the reflection layer may be formed of aluminum-palladium-copper (APC) alloy.


A bank layer 166 is formed on the passivation layer 150 to cover an edge of the first electrode 160. Namely, the bank layer 166 is positioned at a boundary of the pixel and exposes a center of the first electrode 160 in the pixel.


An organic emitting layer 162 is formed on the first electrode 160. The organic emitting layer 162 may have a single-layered structure of an emitting material layer including an emitting material. To increase an emitting efficiency of the OLED D and/or the organic light emitting display device 100, the organic emitting layer 162 may have a multi-layered structure.


The organic emitting layer 162 is separated in each of the red, green and blue pixels. As illustrated below, the organic emitting layer 162 in the blue pixel includes a host of an anthracene derivative and a dopant of a pyrene derivative, and at least one of the anthracene derivative and the pyrene derivative is deuterated. As a result, the emitting efficiency and the lifespan of the OLED D in the blue pixel are improved.


A second electrode 164 is formed over the substrate 110 where the organic emitting layer 162 is formed. The second electrode 164 covers an entire surface of the display area and may be formed of a conductive material having a relatively low work function to serve as a cathode. For example, the second electrode 164 may be formed of aluminum (Al), magnesium (Mg), silver (Ag), Al-Mg alloy (AlMg) or Mg-Ag alloy (MgAg).


The first electrode 160, the organic emitting layer 162 and the second electrode 164 constitute the OLED D.


An encapsulation film 170 is formed on the second electrode 164 to prevent penetration of moisture into the OLED D. The encapsulation film 170 includes a first inorganic insulating layer 172, an organic insulating layer 174 and a second inorganic insulating layer 176 sequentially stacked, but it is not limited thereto. The encapsulation film 170 may be omitted.


A polarization plate (not shown) for reducing an ambient light reflection may be disposed over the top-emission type OLED D. For example, the polarization plate may be a circular polarization plate.


In addition, a cover window (not shown) may be attached to the encapsulation film 170 or the polarization plate. In this instance, the substrate 110 and the cover window have a flexible property such that a flexible display device may be provided.



FIG. 3 is a schematic cross-sectional view illustrating an OLED having a single emitting part for the organic light emitting display device according to the first embodiment of the present disclosure.


As illustrated in FIG. 3, the OLED D includes the first and second electrodes 160 and 164, which face each other, and the organic emitting layer 162 therebetween. The organic emitting layer 162 includes an emitting material layer (EML) 240 between the first and second electrodes 160 and 164.


The first electrode 160 may be formed of a conductive material having a relatively high work function to serve as an anode. The second electrode 164 may be formed of a conductive material having a relatively low work function to serve as a cathode. One of the first and second electrodes 160 and 164 is a transparent electrode (or a semi-transparent electrode), and the other one of the first and second electrodes 160 and 164 is a reflective electrode.


The organic emitting layer 162 may further include an electron blocking layer (EBL) 230 between the first electrode 160 and the EML 240 and a hole blocking layer (HBL) 250 between the EML 240 and the second electrode 164.


In addition, the organic emitting layer 162 may further include a hole transporting layer (HTL) 220 between the first electrode 160 and the EBL 230.


Moreover, the organic emitting layer 162 may further include a hole injection layer (HIL) 210 between the first electrode 160 and the HTL 220 and an electron injection layer (EIL) 260 between the second electrode 164 and the HBL 250.


In the OLED D of the present disclosure, the HBL 250 may include a hole blocking material of an azine derivative and/or a benzimidazole derivative. The hole blocking material has an electron transporting property such that an electron transporting layer may be omitted. The HBL 250 directly contacts the EIL 260. Alternatively, the HBL may directly contact the second electrode without the EIL 260. However, an electron transporting layer may be formed between the HBL 250 and the EIL 260.


The organic emitting layer 162, e.g., the EML 240, includes the host 242 of an anthracene derivative, the dopant 244 of a pyrene derivative and provides blue emission. In this case, at least one of the anthracene derivative 242 and the pyrene derivative 244 is deuterated.


The anthracene derivative as the host 242 may be represented by Formula 1:




embedded image - Formula 1


In Formula 1, each of R1 and R2 is independently C6∼C30 aryl group or C5∼C30 heteroaryl group, each of L1, L2, L3 and L4 is independently C6∼C30 arylene group, and each of a, b, c and d is an integer of 0 or 1. Hydrogens in the anthracene derivative of Formula 1 are non-deuterated, partially deuterated or wholly deuterated.


For example, each of R1 and R2 may be selected from the group consisting of phenyl, naphthyl, dimethylfluorenyl, dibenzofuranyl, dibenzothiophenyl, phenanthrenyl, and carbazolyl. The dimethylfluorenyl, dibenzofuranyl, dibenzothiophenyl, phenanthrenyl, and carbazolyl may be substituted by C6∼C30 aryl group, e.g., phenyl or naphthyl. Each of L1, L2, L3 and L4 may be phenylene or naphthylene, and at least one of a, b, c and d may be 0.


The pyrene derivative as the dopant 244 may be represented by Formula 2:




embedded image - Formula 2


In Formula 2, each of X1 and X2 is independently O or S, each of Ar1 and Ar2 is independently C6∼C30 aryl group or C5∼C30 heteroaryl group, and R3 is C1~C10 alkyl group or C1∼C10 cycloalkyl group. In addition, g is an integer of 0 to 2. Hydrogens in the pyrene derivative of Formula 2 is non-deuterated, partially deuterated or wholly deuterated.


The EML 240 includes the anthracene derivative as the host 242 and the pyrene derivative as the dopant 244, and at least one hydrogen atom in the anthracene derivative and the pyrene derivative is substituted by a deuterium atom. Namely, at least one of the anthracene derivative and the pyrene derivative is deuterated.


In the EML 240, when the anthracene derivative as the host 242 is deuterated (e.g., “deuterated anthracene derivative”), the hydrogen atoms in the pyrene derivative as the dopant 244 may be non-deuterated (e.g., “non-deuterated pyrene derivative”), a part of the hydrogen atoms in the pyrene derivative as the dopant 244 may be deuterated (e.g., “partially-deuterated pyrene derivative”), or all of the hydrogen atoms in the pyrene derivative as the dopant 244 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). On the other hand, when the pyrene derivative as the dopant 244 is deuterated (e.g., “deuterated pyrene derivative”), the hydrogen atoms in the anthracene derivative as the host 242 may be non-deuterated (e.g., “non-deuterated anthracene derivative”), a part of the hydrogen atoms in the anthracene derivative as the host 242 may be deuterated (e.g., “partially-deuterated anthracene derivative”), or all of the hydrogen atoms in the anthracene derivative as the host 242 may be deuterated (e.g., “wholly-deuterated anthracene derivative”).


At least one of the anthracene derivative as the host 242 and the pyrene derivative as the dopant 244 may be wholly deuterated.


For example, when the anthracene derivative as the host 242 is wholly deuterated (e.g., “wholly-deuterated anthracene derivative”), the hydrogen atoms in the pyrene derivative as the dopant 244 may be non-deuterated (e.g., “non-deuterated pyrene derivative”), a part of the hydrogen atoms in the pyrene derivative as the dopant 244 may be deuterated (e.g., “partially-deuterated pyrene derivative”), or all of the hydrogen atoms in the pyrene derivative as the dopant 244 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). On the other hand, when the pyrene derivative as the dopant 244 is wholly deuterated (e.g., “wholly-deuterated pyrene derivative”), the hydrogen atoms in the anthracene derivative as the host 242 may be non-deuterated (e.g., “non-deuterated anthracene derivative”), a part of the hydrogen atoms in the anthracene derivative as the host 242 may be deuterated (e.g., “partially-deuterated anthracene derivative”), or all of the hydrogen atoms in the anthracene derivative as the host 242 may be deuterated (e.g., “wholly-deuterated anthracene derivative”).


As a result, the emitting efficiency and the lifespan of the OLED D are significantly increased.


At least one of an anthracene core of the host 242 and a pyrene core of the dopant 244 may be deuterated.


For example, when the anthracene core of the host 242 is deuterated (e.g., “core-deuterated anthracene derivative”), the dopant 244 may be non-deuterated (e.g., “non-deuterated pyrene derivative”) or all of the pyrene core and a substituent of the dopant 244 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). Alternatively, the pyrene core of the dopant 244 except the substituent may be deuterated (e.g., “core-deuterated pyrene derivative”), or the substituent of the dopant 244 except the pyrene core may be deuterated (e.g., “substituent-deuterated pyrene derivative”).


On the other hand, in the EML 240, when the pyrene core of the dopant 244 is deuterated (e.g., “core-deuterated pyrene derivative”), the host 242 may be non-deuterated (e.g., “non-deuterated anthracene derivative”) or all of the anthracene core and a substituent of the host 242 may be deuterated (e.g., “wholly-deuterated anthracene derivative”). Alternatively, the anthracene core of the host 242 except the substituent may be deuterated (e.g., “core-deuterated anthracene derivative”), or the substituent of the host 242 except the anthracene core may be deuterated (e.g., “substituent-deuterated anthracene derivative”).


The anthracene derivative as the host 242, in which the anthracene core is deuterated, may be represented by Formula 3:




embedded image - Formula 3


In Formula 3, each of R1 and R2 is independently C6∼C30 aryl group or C5∼C30 heteroaryl group, and each of L1, L2, L3 and L4 is independently C6∼C30 arylene group, each of a, b, c and d is an integer of 0 or 1, and e is an integer of 1 to 8.


Namely, in the core-deuterated anthracene derivative as the host 242, the anthracene moiety as the core is substituted by deuterium (D), and the substituent except the anthracene moiety is not deuterated.


For example, each of R1 and R2 may be selected from the group consisting of phenyl, naphthyl, dimethylfluorenyl, dibenzofuranyl, dibenzothiophenyl, phenanthrenyl, and carbazolyl. The dimethylfluorenyl, dibenzofuranyl, dibenzothiophenyl, phenanthrenyl, and carbazolyl may be substituted by C6∼C30 aryl group, e.g., phenyl or naphthyl. Each of L1, L2, L3 and L4 may be phenylene or naphthylene. At least one of a, b, c and d may be 0, and e may be 8.


In an exemplary embodiment, the host 242 may be a compound being one of the followings in Formula 4:




embedded image - Formula 4




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image


The pyrene derivative as the dopant 244, in which the pyrene core is deuterated, may be represented by Formula 5:




embedded image - Formula 5


In Formula 5, each of X1 and X2 is independently O or S, each of Ar1 and Ar2 is independently C6∼C30 aryl group or C5∼C30 heteroaryl group, and R3 is C1~C10 alkyl group or C1∼C10 cycloalkyl group. In addition, f is an integer of 1 to 8, g is an integer of 0 to 2, and a summation of f and g is 8 or less.


Namely, in the core-deuterated pyrene derivative as the dopant 244, the pyrene moiety as the core is substituted by deuterium (D), and the substituent except the pyrene moiety is not deuterated.


For example, each of Ar1 and Ar2 may be selected from the group consisting of phenyl, dibenzofuranyl, dibenzothiophenyl, dimethylfluorenyl, pyridyl, and quinolinyl and may be substituted by C1~C10 alkyl group or C1~C10 cycloalkyl group, trimethylsilyl, or trifluoromethyl. In addition, R3 may be methyl, ethyl, propyl, butyl, heptyl, cyclopentyl, cyclobutyl, or cyclopropyl.


In an exemplary embodiment, the dopant 244 may be a compound being one of the followings in Formula 6:




embedded image - Formula 6




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image


For example, when the host 242 is a compound of Formula 3, the dopant 244 may be a compound of one of Formula 5 and Formulas 7-1 to 7-3.




embedded image - [Formula 7-1]




embedded image - [Formula 7-2]




embedded image - [Formula 7-3]


In Formulas 7-1 to 7-3, each of X1 and X2 is independently O or S, each of An and Ar2 is independently C6~C30 aryl group or C5~C30 heteroaryl group, and R3 is C1~C10 alkyl group or C1~C10 cycloalkyl group. In addition, each of f1 and f2 is independently an integer of 1 to 7, and g1 is an integer of 0 to 8. In Formula 7-3, f3 is an integer of 1 to 8, g2 is an integer of 0 to 2, and a summation of f3 and g2 is 8. In addition, a part or all of hydrogen atoms of Ar1 and Ar2 may be substituted by D.


When the dopant 244 is a compound of Formula 5, the host 242 is a compound of Formula 3, a compound of Formula 3, in which at least one of L1, L2, L3, L4, R1 and R2 is deuterated, or a compound of Formula 3, in which the anthracene core is not deuterated (e=0) and at least one of L1, L2, L3, L4, R1 and R2 is deuterated. Namely, the host 242 may be the core-deuterated anthracene derivative, the wholly-deuterated anthracene derivative or the substituent-deuterated anthracene derivative.


In the EML 240 of the OLED D, the host 242 may have a weight % of about 70 to 99.9, and the dopant 244 may have a weight % of about 0.1 to 30. To provide sufficient emitting efficiency and lifespan, a weight % of the dopant 244 may be about 0.1 to 10, preferably about 1 to 5.


The EBL 230 includes an amine derivative as an electron blocking material. The material of the EBL 230 may be represented by Formula 8:




embedded image - Formula 8


In Formula 8, L is arylene group, and a is 0 or 1. Each of R1 and R2 is independently selected from the group consisting of C6 to C30 arylene group and C5 to C30 heteroarylene group.


For example, L may be phenylene, and each of R1 and R2 may be selected from the group consisting of biphenyl, fluorenyl, phenylcarbazolyl, carbazolylphenyl, dibenzothiophenyl and dibenzofuranyl.


Namely, the electron blocking material may be an amine derivative substituted by spirofluorene (e.g., “spirofluorene-substituted amine derivative”).


The electron blocking material of Formula 8 may be one of the followings of Formula 9: Formula 9




embedded image - H1




embedded image - H2




embedded image - H3




embedded image - H4




embedded image - H5




embedded image - H6




embedded image - H7




embedded image - H8




embedded image - H9


The HBL 250 may include an azine derivative as a hole blocking material. For example, the material of the HBL 250 may be represented by Formula 10:




embedded image - Formula 10


In Formula 10, each of Y1 to Y5 are independently CR1 or N, and one to three of Y1 to Y5 is N. R1 is independently hydrogen or C6~C30 aryl group. L is C6~C30 arylene group, and R2 is C6~C30 aryl group or C5~C30 hetero aryl group. R3 is hydrogen, or adjacent two of R3 form a fused ring. “a” is 0 or 1, “b” is 1 or 2, and “c” is an integer of 0 to 4.


The hole blocking material of Formula 10 may be one of the followings of Formula 11: Formula 11




embedded image - E1




embedded image - E2




embedded image - E3




embedded image - E4




embedded image - E5




embedded image - E6




embedded image - E7




embedded image - E8




embedded image - E9




embedded image - E10




embedded image - E11




embedded image - E12




embedded image - E13




embedded image - E14




embedded image - E15




embedded image - E16




embedded image - E17




embedded image - E18




embedded image




embedded image - E21




embedded image - E22




embedded image - E23


Alternatively, the HBL 250 may include a benzimidazole derivative as a hole blocking material. For example, the material of the HBL 250 may be represented by Formula 12:




embedded image - Formula 12


In Formula 12, Ar is C10~C30 arylene group, R1 is C6~C30 aryl group or C5~C30 hetero aryl group, and R2 is C1~C10 alkyl group or C6~C30 aryl group.


For example, Armay benaphthylene or anthracenylene, R1 may be benzimidazole or phenyl, and R2 may be methyl, ethyl or phenyl.


The hole blocking material of Formula 12 may be one of the followings of Formula 13: Formula 13




embedded image - F1




embedded image - F2




embedded image - F3




embedded image - F4




embedded image - F5




embedded image - F6


The HBL 250 may include one of the hole blocking material of Formula 10 and the hole blocking material of Formula 12.


In this instance, a thickness of the EML 240 may be greater than each of a thickness of the EBL 230 and a thickness of the HBL 250 and may be smaller than a thickness of the HTL 220. For example, the EML may have a thickness of about 150 to 250 Å, and each of the EBL 230 and the HBL 250 may have a thickness of about 50 to 150 Å. The HTL 220 may have a thickness of about 900 to 1100 Å. The EBL 230 and the HBL 250 may have the same thickness.


The HBL 250 may include both the hole blocking material of Formula 10 and the hole blocking material of Formula 12. For example, in the HBL 250, hole blocking material of Formula 10 and the hole blocking material of Formula 12 may have the same weight %.


In this instance, a thickness of the EML 240 may be greater than a thickness of the EBL 230 and may be smaller than a thickness of the HBL 250. In addition, the thickness of HBL 250 may be smaller than a thickness of the HTL 220. For example, the EML may have a thickness of about 200 to 300 Å, and the EBL 230 may have a thickness of about 50 to 150 Å. The HBL 250 may have a thickness of about 250 to 350 Å, and the HTL 220 may have a thickness of about 800 to 1000 Å.


The hole blocking material of Formula 10 and/or the hole blocking material of Formula 12 have an electron transporting property such that an electron transporting layer may be omitted. As a result, the HBL 250 directly contacts the EIL 260 or the second electrode 164 without the EIL 260.


As mentioned above, the EML 240 of the OLED D includes the host 242 of the anthracene derivative, the dopant 244 of the pyrene derivative, and at least one of the anthracene derivative 242 and the pyrene derivative 244 is deuterated. As a result, the OLED D and the organic light emitting display device 100 have advantages in the emitting efficiency and the lifespan.


When all of the hydrogen atoms of the anthracene derivative and/or all of the hydrogen atoms of the pyrene derivative are substituted by D, the emitting efficiency and the lifespan of the OLED D and the organic light emitting display device 100 are significantly increased.


When at least one of an anthracene core of the anthracene derivative 242 and a pyrene core of the pyrene derivative 244 is deuterated, the OLED D and the organic light emitting display device 100 have sufficient emitting efficiency and lifespan with minimizing the production cost increase.


In addition, the EBL 230 includes the electron blocking material of Formula 8 such that the emitting efficiency and the lifespan of the OLED D and the organic light emitting display device 100 are further improved.


Moreover, the HBL 250 includes at least one of the hole blocking material of Formula 10 and the hole blocking material of Formula 12 such that the lifespan of the OLED D and the organic light emitting display device 100 are further improved.


Synthesis of the Host
1. Synthesis of the Compound Host1D
Compound H-1



embedded image - [Reaction Formula 1-1]


The compound A (11.90 mmol) and and the compound B (13.12 mmol) were dissolved in toluene (100 mL), Pd(PPh3)4 (0.59 mmol) and 2 M K2CO3 (24 mL) were slowly added into the mixture. The mixture was reacted for 48 hours. After cooling, the temperature is set to the room temperature, and the solvent was removed under the reduced pressure. The reaction mixture was extracted with chloroform. The extracted solution was washed twice with sodium chloride supersaturated solution and water, and then the organic layer was collected and dried over anhydrous magnesium sulfate. Thereafter, the solvent was evaporated to obtain a crude product, and the column chromatography using silica gel was performed to the crude product to obtain the compound H-1. (2.27 g, 57%)


Compound Host1D



embedded image - [Reaction Formula 1-2]


The compound H-1 (5.23 mmol), the compound C (5.74 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.26 mmol) and toluene (50 mL) were added to the flask (250 mL) in a glove box. After the reaction flask was removed from the drying box, degassed aqueous sodium carbonate (2 M, 20 mL) was added to the mixture. The mixture was stirred and heated at 90° C. overnight. The reaction was monitored by high-performance liquid chromatography (HPLC). After cooling to the room temperature, the organic layer was separated. The aqueous layer was washed twice with dichloromethane (DCM), and the organic layer was concentrated by rotary evaporation to obtain a gray powder. The compound Host1D was obtained by performing purification using neutral alumina, precipitation using hexane, and column chromatography using silica gel. (2.00 g, 89%)


2. Synthesis of the Compound Host2D
Compound H-2



embedded image - [Reaction Formula 2-1]


In the synthesis of the compound H-1, the compound D was used instead of the compound B to obtain the compound H-2.


Compound Host2D



embedded image - [Reaction Formula 2-2]


The compound H-2 (5.23 mmol), the compound E (5.74 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.26 mmol) and toluene (50 mL) were added to the flask (250 mL) in a glove box. After the reaction flask was removed from the drying box, degassed aqueous sodium carbonate (2 M, 20 mL) was added to the mixture. The mixture was stirred and heated at 90° C. overnight. The reaction was monitored by HPLC. After cooling to the room temperature, the organic layer was separated. The aqueous layer was washed twice with DCM, and the organic layer was concentrated by rotary evaporation to obtain a gray powder. The compound Host2D was obtained by performing purification using neutral alumina, precipitation using hexane, and column chromatography using silica gel. (2.28 g, 86%)


3. Synthesis of the Compound Host3D
Compound H-3



embedded image - [Reaction Formula 3-1]


In the synthesis of the compound H-1, the compound F was used instead of the compound B to obtain the compound H-3.


Compound Host3D



embedded image - [Reaction Formula 3-2]


The compound H-3 (5.23 mmol), the compound G (5.74 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.26 mmol) and toluene (50 mL) were added to the flask (250 mL) in a glove box. After the reaction flask was removed from the drying box, degassed aqueous sodium carbonate (2 M, 20 mL) was added to the mixture. The mixture was stirred and heated at 90° C. overnight. The reaction was monitored by HPLC. After cooling to the room temperature, the organic layer was separated. The aqueous layer was washed twice with DCM, and the organic layer was concentrated by rotary evaporation to obtain a gray powder. The compound Host3D was obtained by performing purification using neutral alumina, precipitation using hexane, and column chromatography using silica gel. (1.71 g, 78%)


4. Synthesis of the Compound Host4D



embedded image - [Reaction Formula 4]


The compound H-3 (5.23 mmol), the compound H (5.74 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.26 mmol) and toluene (50 mL) were added to the flask (250 mL) in a glove box. After the reaction flask was removed from the drying box, degassed aqueous sodium carbonate (2 M, 20 mL) was added to the mixture. The mixture was stirred and heated at 90° C. overnight. The reaction was monitored by HPLC. After cooling to the room temperature, the organic layer was separated. The aqueous layer was washed twice with DCM, and the organic layer was concentrated by rotary evaporation to obtain a gray powder. The compound Host4D was obtained by performing purification using neutral alumina, precipitation using hexane, and column chromatography using silica gel. (1.75 g, 67%)


Synthesis of the Dopant
1. Synthesis of the Compound Dopant1D
Compound D-1



embedded image - [Reaction Formula 5-1]


Under argon conditions, dibenzofuran (30.0 g) and dehydrated tetrahydrofuran (THF, 300 mL) were added to a distillation flask (1000 mL). The mixture was cooled to -65° C., and n-butyllithium hexane solution (1.65 M, 120 mL) was added. The mixture was slowly heated up and reacted at the room temperature for 3 hours. After the mixture was cooled to -65° C. again, 1,2-dibromoethane (23.1 mL) was added. The mixture was slowly heated up and reacted at the room temperature for 3 hours. 2N hydrochloric acid and ethyl acetate were added into the mixture for separation and extraction, and the organic layer was washed with water and saturated brine and dried over sodium sulfate. The crude product obtained by concentration was purified by silica gel chromatography using methylene chloride, and the obtained solid was dried under reduced pressure to obtain the compound D-1. (43.0 g)


Compound D-2



embedded image - [Reaction Formula 5-2]


Under argon conditions, the compound D-1 (11.7 g), the compound B (10.7 mL), tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3, 0.26 mmol), 2,2′-bis(diphenylphosphino)-1,1′-binapthyl (BINAP, 0.87 g), sodium tert-butoxide (9.1 g), and dehydrated toluene (131 mL) were added to a distillation flask (300 mL) and reacted at 85° C. for 6 hours. After cooling, the reaction solution was filtered through celite. The obtained crude product was purified by silica gel chromatography using n-hexane and methylene chloride (volume ratio = 3:1), and the obtained solid was dried under reduced pressure to obtain compound D-2. (10.0 g)


Compound Dopant1D



embedded image - [Reaction Formula 5-3]


Under argon conditions, the compound D-2 (8.6 g), the compound C (4.8 g), sodium tert-butoxide (2.5 g), palladium(II)acetate (Pd(OAc)2, 150 mg), tri-tert-butylphosphine (135 mg), and dehydrated toluene (90 mL) were added into a distillation flask (300 mL) and reacted at 85° C. for 7 hours. The reaction solution was filtered, and the obtained crude product was purified by silica gel chromatography using toluene. The obtained solid was recrystallized using toluene and dried under reduced pressure to obtain the compound Dopant1D. (8.3 g)


2. Synthesis of the Compound Dopant2D



embedded image - [Reaction Formula 6]


In the synthesis of the compound Dopant1D, the compound D was used instead of the compound C to obtain the compound Dopant2D.


Organic Light Emitting Diode

The anode (ITO, 0.5 mm), the HIL (Formula 13 (97 wt%) and Formula 14 (3 wt%), 100 Å), the HTL (Formula 13, 1000 Å), the EBL (100 Å), the EML (host (98 wt%) and dopant (2 wt%), 200 Å), the HBL (100 Å), the EIL (Formula 15 (98 wt%) and Li (2 wt%), 200 Å) and the cathode (Al, 500 Å) was sequentially deposited, and an encapsulation film was formed on the cathode using UV epoxy resin and moisture getter to form the OLED.




embedded image - [Formula 13]




embedded image - [Formula 14]




embedded image - [Formula 15]


1. Comparative Examples
Comparative Examples 1 to 6 (Ref1 to Ref6)

The compound “Dopant1” in Formula 16 is used as the dopant, and the compound “Host1” of Formula 17 are used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


Comparative Examples 7 to 12 (Ref7 to Ref12)

The compound “Dopant1” in Formula 16 is used as the dopant, and the compound “Host2” of Formula 17 are used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


Comparative Examples 13 to 18 (Ref13 to Ref18)

The compound “Dopant1” in Formula 16 is used as the dopant, and the compound “Host3” of Formula 17 are used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


Comparative Examples 19 to 24 (Ref19 to Ref24)

The compound “Dopant1” in Formula 16 is used as the dopant, and the compound “Host4” of Formula 17 are used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


Comparative Examples 25 to 30 (Ref25 to Ref30)

The compound “Dopant2” in Formula 16 is used as the dopant, and the compound “Host1” of Formula 17 are used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


Comparative Examples 31 to 36 (Ref31 to Ref36)

The compound “Dopant2” in Formula 16 is used as the dopant, and the compound “Host2” of Formula 17 are used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


Comparative Examples 37 to 42 (Ref37 to Ref42)

The compound “Dopant2” in Formula 16 is used as the dopant, and the compound “Host3” of Formula 17 are used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


Comparative Examples 43 to 48 (Ref43 to Ref48)

The compound “Dopant2” in Formula 16 is used as the dopant, and the compound “Host4” of Formula 17 are used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


2. EXAMPLES
1 Examples 1 to 24 Ex1 to Ex24

The compound “Dopant1” in Formula 16 is used as the dopant, and the compounds “Host1D”, “Host1D-A”, “Host1D-P1”, “Host1D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


2 Examples 25 to 54 Ex25 to Ex54

The compound “Dopant1D” in Formula 16 is used as the dopant, and the compounds “Host1”, “Host1D”, “Host1D-A”, “Host1D-P1”, “Host1D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


3 Examples 55 to 84 Ex55 to Ex84

The compound “Dopant1D-A” in Formula 16 is used as the dopant, and the compounds “Host1”, “Host1D”, “Host1D-A”, “Host1D-P1”, “Host1D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


4 Examples 85 to 108 Ex85 to Ex108

The compound “Dopant1” in Formula 16 is used as the dopant, and the compounds “Host2D”, “Host2D-A”, “Host2D-P1”, “Host2D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


5 Examples 109 to 138 Ex109 to Ex138

The compound “Dopant1D” in Formula 16 is used as the dopant, and the compounds “Host2”, “Host2D”, “Host2D-A”, “Host2D-P1”, “Host2D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


6 Examples 139 to 168 Ex139 to Ex168

The compound “Dopant1D-A” in Formula 16 is used as the dopant, and the compounds “Host2”, “Host2D”, “Host2D-A”, “Host2D-P1”, “Host2D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


7 Examples 169 to 192 Ex169 to Ex192

The compound “Dopant1” in Formula 16 is used as the dopant, and the compounds “Host3D”, “Host3D-A”, “Host3D-P1”, “Host3D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


8 Examples 193 to 222 Ex193 to Ex222

The compound “Dopant1D” in Formula 16 is used as the dopant, and the compounds “Host3”, “Host3D”, “Host3D-A”, “Host3D-P1”, “Host3D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


9 Examples 223 to 252 Ex223 to Ex252

The compound “Dopant1D-A” in Formula 16 is used as the dopant, and the compounds “Host3”, “Host3D”, “Host3D-A”, “Host3D-P1”, “Host3D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


10 Examples 253 to 276 Ex253 to Ex276

The compound “Dopant1” in Formula 16 is used as the dopant, and the compounds “Host4D”, “Host4D-A”, “Host4D-P1”, “Host4D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


11 Examples 277 to 306 Ex277 to Ex306

The compound “Dopant1D” in Formula 16 is used as the dopant, and the compounds “Host4”, “Host4D”, “Host4D-A”, “Host4D-P1”, “Host4D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


12 Examples 307 to 336 Ex307 to Ex336

The compound “Dopant1D-A” in Formula 16 is used as the dopant, and the compounds “Host4”, “Host4D”, “Host4D-A”, “Host4D-P1”, “Host4D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


13 Examples 337 to 360 Ex337 to Ex360

The compound “Dopant2” in Formula 16 is used as the dopant, and the compounds “Host1D”, “Host1D-A”, “Host1D-P1”, “Host1D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


14 Examples 361 to 390 Ex361 to Ex390

The compound “Dopant2D” in Formula 16 is used as the dopant, and the compounds “Host1”, “Host1D”, “Host1D-A”, “Host1D-P1”, “Host1D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


15 Examples 391 to 420 Ex391 to Ex420

The compound “Dopant2D-A” in Formula 16 is used as the dopant, and the compounds “Host1”, “Host1D”, “Host1D-A”, “Host1D-P1”, “Host1D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


16 Examples 421 to 444 Ex421 to Ex444

The compound “Dopant2” in Formula 16 is used as the dopant, and the compounds “Host2D”, “Host2D-A”, “Host2D-P1”, “Host2D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


17 Examples 445 to 474 Ex445 to Ex474

The compound “Dopant2D” in Formula 16 is used as the dopant, and the compounds “Host2”, “Host2D”, “Host2D-A”, “Host2D-P1”, “Host2D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


18 Examples 475 to 504 Ex475 to Ex504

The compound “Dopant2D-A” in Formula 16 is used as the dopant, and the compounds “Host2”, “Host2D”, “Host2D-A”, “Host2D-P1”, “Host2D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


19 Examples 505 to 528 Ex505 to Ex528

The compound “Dopant2” in Formula 16 is used as the dopant, and the compounds “Host3D”, “Host3D-A”, “Host3D-P1”, “Host3D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


20 Examples 529 to 558 Ex529 to Ex558

The compound “Dopant2D” in Formula 16 is used as the dopant, and the compounds “Host3”, “Host3D”, “Host3D-A”, “Host3D-P1”, “Host3D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


21 Examples 559 to 588 Ex559 to Ex588

The compound “Dopant2D-A” in Formula 16 is used as the dopant, and the compounds “Host3”, “Host3D”, “Host3D-A”, “Host3D-P1”, “Host3D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


22 Examples 589 to 612 Ex589 to Ex612

The compound “Dopant2” in Formula 16 is used as the dopant, and the compounds “Host4D”, “Host4D-A”, “Host4D-P1”, “Host4D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


23 Examples 613 to 642 Ex613 to Ex642

The compound “Dopant2D” in Formula 16 is used as the dopant, and the compounds “Host4”, “Host4D”, “Host4D-A”, “Host4D-P1”, “Host4D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material.


24 Examples 643 to 672 Ex643 to Ex672

The compound “Dopant2D-A” in Formula 16 is used as the dopant, and the compounds “Host4”, “Host4D”, “Host4D-A”, “Host4D-P1”, “Host4D-P2” of Formula 17 are respectively used as the host to form the EML. The compounds “Ref_EBL” (Ref) of Formula 18 and “EBL” of Formula 19 are respectively used as the electron blocking material, and the compound “Ref_HBL” (Ref) of Formula 20, the compound “HBL1” of Formula 21 and the compound “HBL2” of Formula 22 are respectively used as the hole blocking material. [Formula 16]




embedded image - Dopant 1




embedded image - Dopant 1D




embedded image - Dopant 1D-A




embedded image - Dopant 2




embedded image - Dopant 2D




embedded image - Dopant 2D-A


[Formula 17]




embedded image - Host 1




embedded image - Host 1D




embedded image - Host 1D-A




embedded image - Host 1D-P1




embedded image - Host1D-P2




embedded image - Host 2




embedded image - Host 2D




embedded image - Host 2D-A




embedded image - Host 2D-P1




embedded image - Host 2D-P2




embedded image - Host 3




embedded image - Host 3D




embedded image - Host 3D-A




embedded image - Host 3D-P1.




embedded image - Host 3D-P2




embedded image - Host 4




embedded image - Host 4D




embedded image - Host 4D-A




embedded image - Host 4D-A




embedded image - Host 4D-P2




embedded image - [Formula 18]




embedded image - [Formula 19]




embedded image - [Formula 20]




embedded image - [Formula 21]




embedded image - [Formula 22]


The properties, i.e., voltage (V), efficiency (cd/A), color coordinate (CIE), FWHM and lifespan (T95), of the OLEDs manufactured in Comparative Examples 1 to 48 and Examples 1 to 672 are measured and listed in Tables 1 to 40.





TABLE 1














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ref 1
Ref.
Dopant 1
Host 1
Ref.
4.03
4.97
0.1412
0.1039
154


Ref 2
Ref.
Dopant 1
Host 1
HBL1
4.03
5.96
0.1412
0.1039
257


Ref 3
Ref.
Dopant 1
Host 1
HBL2
3.88
6.29
0.1382
0.1019
205


Ref 4
EBL
Dopant 1
Host 1
Ref.
3.83
5.30
0.1382
0.1019
193


Ref 5
EBL
Dopant 1
Host 1
HBL1
3.83
6.62
0.1382
0.1019
321


Ref 6
EBL
Dopant 1
Host 1
HBL2
3.68
7.94
0.1382
0.1009
257


Ex 1
Ref.
Dopant 1
Host 1D
Ref.
4.04
4.95
0.1423
0.1039
264


Ex 2
Ref.
Dopant 1
Host 1D
HBL1
4.04
5.94
0.1423
0.1039
439


Ex 3
Ref.
Dopant 1
Host 1D
HBL2
3.89
6.27
0.1393
0.1019
351


Ex 4
EBL
Dopant 1
Host 1D
Ref.
3.84
5.28
0.1393
0.1019
329


Ex 5
EBL
Dopant 1
Host 1D
HBL1
3.84
6.60
0.1393
0.1019
549


Ex 6
EBL
Dopant 1
Host 1D
HBL2
3.69
7.92
0.1393
0.1009
439


Ex 7
Ref.
Dopant 1
Host 1D-A
Ref.
4.02
4.96
0.1414
0.1038
270


Ex 8
Ref.
Dopant 1
Host 1D-A
HBL1
4.02
5.95
0.1414
0.1038
450


Ex 9
Ref.
Dopant 1
Host 1D-A
HBL2
3.87
6.28
0.1384
0.1018
360


Ex 10
EBL
Dopant 1
Host 1D-A
Ref.
3.82
5.29
0.1384
0.1018
337


Ex 11
EBL
Dopant 1
Host 1D-A
HBL1
3.82
6.61
0.1384
0.1018
562


Ex 12
EBL
Dopant 1
Host 1D-A
HBL2
3.67
7.93
0.1384
0.1008
450









TABLE 2














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 13
Ref.
Dopant 1
Host 1D-P1
Ref.
4.03
4.95
0.1411
0.1040
154


Ex 14
Ref.
Dopant 1
Host 1D-P1
HBL1
4.03
5.94
0.1411
0.1040
256


Ex 15
Ref.
Dopant 1
Host 1D-P1
HBL2
3.88
6.27
0.1381
0.1020
205


Ex 16
EBL
Dopant 1
Host 1D-P1
Ref.
3.83
5.28
0.1381
0.1020
192


Ex 17
EBL
Dopant 1
Host 1D-P1
HBL1
3.83
6.60
0.1381
0.1020
320


Ex 18
EBL
Dopant 1
Host 1D-P1
HBL2
3.68
7.92
0.1381
0.1010
256


Ex 19
Ref.
Dopant 1
Host 1D-P2
Ref.
4.04
4.97
0.1415
0.1039
154


Ex 20
Ref.
Dopant 1
Host 1D-P2
HBL1
4.04
5.96
0.1415
0.1039
257


Ex 21
Ref.
Dopant 1
Host 1D-P2
HBL2
3.89
6.29
0.1385
0.1019
205


Ex 22
EBL
Dopant 1
Host 1D-P2
Ref.
3.84
5.30
0.1385
0.1019
193


Ex 23
EBL
Dopant 1
Host 1D-P2
HBL1
3.84
6.62
0.1385
0.1019
321


Ex 24
EBL
Dopant 1
Host 1D-P2
HBL2
3.69
7.94
0.1385
0.1009
257


Ex 25
Ref.
Dopant 1D
Host 1
Ref.
4.03
4.96
0.1420
0.1038
200


Ex 26
Ref.
Dopant 1D
Host 1
HBL1
4.03
5.95
0.1420
0.1038
334


Ex 27
Ref.
Dopant 1D
Host 1
HBL2
3.88
6.28
0.1390
0.1018
267


Ex 28
EBL
Dopant 1D
Host 1
Ref.
3.83
5.29
0.1390
0.1018
250


Ex 29
EBL
Dopant 1D
Host 1
HBL1
3.83
6.61
0.1390
0.1018
417


Ex 30
EBL
Dopant 1D
Host 1
HBL2
3.68
7.93
0.1390
0.1008
334









TABLE 3














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 31
Ref.
Dopant 1D
Host 1D
Ref.
4.03
4.96
0.1422
0.1038
338


Ex 32
Ref.
Dopant 1D
Host 1D
HBL1
4.03
5.95
0.1422
0.1038
563


Ex 33
Ref.
Dopant 1D
Host 1D
HBL2
3.88
6.28
0.1392
0.1018
451


Ex 34
EBL
Dopant 1D
Host 1D
Ref.
3.83
5.29
0.1392
0.1018
422


Ex 35
EBL
Dopant 1D
Host 1D
HBL1
3.83
6.61
0.1392
0.1018
704


Ex 36
EBL
Dopant 1D
Host 1D
HBL2
3.68
7.93
0.1392
0.1008
563


Ex 37
Ref.
Dopant 1D
Host 1D-A
Ref.
4.04
4.95
0.1420
0.1039
350


Ex 38
Ref.
Dopant 1D
Host 1D-A
HBL1
4.04
5.94
0.1420
0.1039
584


Ex 39
Ref.
Dopant 1D
Host 1D-A
HBL2
3.89
6.27
0.1390
0.1019
467


Ex 40
EBL
Dopant 1D
Host 1D-A
Ref.
3.84
5.28
0.1390
0.1019
438


Ex 41
EBL
Dopant 1D
Host 1D-A
HBL1
3.84
6.60
0.1390
0.1019
730


Ex 42
EBL
Dopant 1D
Host 1D-A
HBL2
3.69
7.92
0.1390
0.1009
584


Ex 43
Ref.
Dopant 1D
Host 1D-P1
Ref.
4.02
4.96
0.1421
0.1040
200


Ex 44
Ref.
Dopant 1D
Host 1D-P1
HBL1
4.02
5.95
0.1421
0.1040
334


Ex 45
Ref.
Dopant 1D
Host 1D-P1
HBL2
3.87
6.28
0.1391
0.1020
267


Ex 46
EBL
Dopant 1D
Host 1D-P1
Ref.
3.82
5.29
0.1391
0.1020
250


Ex 47
EBL
Dopant 1D
Host 1D-P1
HBL1
3.82
6.61
0.1391
0.1020
417


Ex 48
EBL
Dopant 1D
Host 1D-P1
HBL2
3.67
7.93
0.1391
0.1010
334









TABLE 4














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 49
Ref.
Dopant 1D
Host 1D-P2
Ref.
4.03
4.97
0.1418
0.1041
201


Ex 50
Ref.
Dopant 1D
Host 1D-P2
HBL1
4.03
5.97
0.1418
0.1041
334


Ex 51
Ref.
Dopant 1D
Host 1D-P2
HBL2
3.88
6.30
0.1388
0.1021
268


Ex 52
EBL
Dopant 1D
Host 1D-P2
Ref.
3.83
5.30
0.1388
0.1021
251


Ex 53
EBL
Dopant 1D
Host 1D-P2
HBL1
3.83
6.63
0.1388
0.1021
418


Ex 54
EBL
Dopant 1D
Host 1D-P2
HBL2
3.68
7.96
0.1388
0.1011
334


Ex 55
Ref.
Dopant 1D-A
Host 1
Ref.
4.02
4.97
0.1416
0.1038
208


Ex 56
Ref.
Dopant 1D-A
Host 1
HBL1
4.02
5.96
0.1416
0.1038
346


Ex 57
Ref.
Dopant 1D-A
Host 1
HBL2
3.87
6.29
0.1386
0.1018
277


Ex 58
EBL
Dopant 1D-A
Host 1
Ref.
3.82
5.30
0.1386
0.1018
260


Ex 59
EBL
Dopant 1D-A
Host 1
HBL1
3.82
6.62
0.1386
0.1018
433


Ex 60
EBL
Dopant 1D-A
Host 1
HBL2
3.67
7.94
0.1386
0.1008
346


Ex 61
Ref.
Dopant 1D-A
Host 1D
Ref.
4.04
4.96
0.1421
0.1038
359


Ex 62
Ref.
Dopant 1D-A
Host 1D
HBL1
4.04
5.95
0.1421
0.1038
598


Ex 63
Ref.
Dopant 1D-A
Host 1D
HBL2
3.89
6.28
0.1391
0.1018
478


Ex 64
EBL
Dopant 1D-A
Host 1D
Ref.
3.84
5.29
0.1391
0.1018
448


Ex 65
EBL
Dopant 1D-A
Host 1D
HBL1
3.84
6.61
0.1391
0.1018
747


Ex 66
EBL
Dopant 1D-A
Host 1D
HBL2
3.69
7.93
0.1391
0.1008
598









TABLE 5














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 67
Ref.
Dopant 1D-A
Host 1D-A
Ref.
4.03
4.96
0.1415
0.1038
366


Ex 68
Ref.
Dopant 1D-A
Host 1D-A
HBL1
4.03
5.95
0.1415
0.1038
610


Ex 69
Ref.
Dopant 1D-A
Host 1D-A
HBL2
3.88
6.28
0.1385
0.1018
488


Ex 70
EBL
Dopant 1D-A
Host 1D-A
Ref.
3.83
5.29
0.1385
0.1018
457


Ex 71
EBL
Dopant 1D-A
Host 1D-A
HBL1
3.83
6.61
0.1385
0.1018
762


Ex 72
EBL
Dopant 1D-A
Host 1D-A
HBL2
3.68
7.93
0.1385
0.1008
610


Ex 73
Ref.
Dopant 1D-A
Host 1D-P1
Ref.
4.03
4.95
0.1417
0.1039
206


Ex 74
Ref.
Dopant 1D-A
Host 1D-P1
HBL1
4.03
5.94
0.1417
0.1039
344


Ex 75
Ref.
Dopant 1D-A
Host 1D-P1
HBL2
3.88
6.27
0.1387
0.1019
275


Ex 76
EBL
Dopant 1D-A
Host 1D-P1
Ref.
3.83
5.28
0.1387
0.1019
258


Ex 77
EBL
Dopant 1D-A
Host 1D-P1
HBL1
3.83
6.60
0.1387
0.1019
430


Ex 78
EBL
Dopant 1D-A
Host 1D-P1
HBL2
3.68
7.92
0.1387
0.1009
344


Ex 79
Ref.
Dopant 1D-A
Host 1D-P2
Ref.
4.04
4.96
0.1416
0.1039
208


Ex 80
Ref.
Dopant 1D-A
Host 1D-P2
HBL1
4.04
5.95
0.1416
0.1039
346


Ex 81
Ref.
Dopant 1D-A
Host 1D-P2
HBL2
3.89
6.28
0.1386
0.1019
277


Ex 82
EBL
Dopant 1D-A
Host 1D-P2
Ref.
3.84
5.29
0.1386
0.1019
260


Ex 83
EBL
Dopant 1D-A
Host 1D-P2
HBL1
3.84
6.61
0.1386
0.1019
433


Ex 84
EBL
Dopant 1D-A
Host 1D-P2
HBL2
3.69
7.93
0.1386
0.1009
346









TABLE 6














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ref 7
Ref.
Dopant 1
Host 2
Ref.
3.84
5.13
0.1413
0.1039
155


Ref 8
Ref.
Dopant 1
Host 2
HBL1
3.84
6.16
0.1413
0.1039
258


Ref 9
Ref.
Dopant 1
Host 2
HBL2
3.69
6.50
0.1383
0.1019
206


Ref 10
EBL
Dopant 1
Host 2
Ref.
3.64
5.47
0.1383
0.1019
193


Ref 11
EBL
Dopant 1
Host 2
HBL1
3.64
6.84
0.1383
0.1019
322


Ref 12
EBL
Dopant 1
Host 2
HBL2
3.49
8.21
0.1383
0.1009
258


Ex 85
Ref.
Dopant 1
Host 2D
Ref.
3.83
5.13
0.1422
0.1040
266


Ex 86
Ref.
Dopant 1
Host 2D
HBL1
3.83
6.16
0.1422
0.1040
443


Ex 87
Ref.
Dopant 1
Host 2D
HBL2
3.68
6.50
0.1392
0.1020
355


Ex 88
EBL
Dopant 1
Host 2D
Ref.
3.63
5.47
0.1392
0.1020
332


Ex 89
EBL
Dopant 1
Host 2D
HBL1
3.63
6.84
0.1392
0.1020
554


Ex 90
EBL
Dopant 1
Host 2D
HBL2
3.48
8.21
0.1392
0.1010
443


Ex 91
Ref.
Dopant 1
Host 2D-A
Ref.
3.83
5.12
0.1420
0.1038
272


Ex 92
Ref.
Dopant 1
Host 2D-A
HBL1
3.83
6.15
0.1420
0.1038
453


Ex 93
Ref.
Dopant 1
Host 2D-A
HBL2
3.68
6.49
0.1390
0.1018
362


Ex 94
EBL
Dopant 1
Host 2D-A
Ref.
3.63
5.46
0.1390
0.1018
340


Ex 95
EBL
Dopant 1
Host 2D-A
HBL1
3.63
6.83
0.1390
0.1018
566


Ex 96
EBL
Dopant 1
Host 2D-A
HBL2
3.48
8.20
0.1390
0.1008
453









TABLE 7














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 97
Ref.
Dopant 1
Host 2D-P1
Ref.
3.84
5.12
0.1421
0.1038
155


Ex 98
Ref.
Dopant 1
Host 2D-P1
HBL1
3.84
6.14
0.1421
0.1038
258


Ex 99
Ref.
Dopant 1
Host 2D-P1
HBL2
3.69
6.48
0.1391
0.1018
206


Ex 100
EBL
Dopant 1
Host 2D-P1
Ref.
3.64
5.46
0.1391
0.1018
193


Ex 101
EBL
Dopant 1
Host 2D-P1
HBL1
3.64
6.82
0.1391
0.1018
322


Ex 102
EBL
Dopant 1
Host 2D-P1
HBL2
3.49
8.18
0.1391
0.1008
258


Ex 103
Ref.
Dopant 1
Host 2D-P2
Ref.
3.82
5.15
0.1422
0.1039
155


Ex 104
Ref.
Dopant 1
Host 2D-P2
HBL1
3.82
6.17
0.1422
0.1039
258


Ex 105
Ref.
Dopant 1
Host 2D-P2
HBL2
3.67
6.52
0.1392
0.1019
207


Ex 106
EBL
Dopant 1
Host 2D-P2
Ref.
3.62
5.49
0.1392
0.1019
194


Ex 107
EBL
Dopant 1
Host 2D-P2
HBL1
3.62
6.86
0.1392
0.1019
323


Ex 108
EBL
Dopant 1
Host 2D-P2
HBL2
3.47
8.23
0.1392
0.1009
258


Ex 109
Ref.
Dopant 1D
Host 2
Ref.
3.83
5.14
0.1422
0.1039
203


Ex 110
Ref.
Dopant 1D
Host 2
HBL1
3.83
6.17
0.1422
0.1039
338


Ex 111
Ref.
Dopant 1D
Host 2
HBL2
3.68
6.51
0.1392
0.1019
270


Ex 112
EBL
Dopant 1D
Host 2
Ref.
3.63
5.48
0.1392
0.1019
253


Ex 113
EBL
Dopant 1D
Host 2
HBL1
3.63
6.85
0.1392
0.1019
422


Ex 114
EBL
Dopant 1D
Host 2
HBL2
3.48
8.22
0.1392
0.1009
338









TABLE 8














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 115
Ref.
Dopant 1D
Host 2D
Ref.
3.84
5.13
0.1424
0.1038
342


Ex 116
Ref.
Dopant 1D
Host 2D
HBL1
3.84
6.16
0.1424
0.1038
570


Ex 117
Ref.
Dopant 1D
Host 2D
HBL2
3.69
6.50
0.1394
0.1018
456


Ex 118
EBL
Dopant 1D
Host 2D
Ref.
3.64
5.47
0.1394
0.1018
428


Ex 119
EBL
Dopant 1D
Host 2D
HBL1
3.64
6.84
0.1394
0.1018
713


Ex 120
EBL
Dopant 1D
Host 2D
HBL2
3.49
8.21
0.1394
0.1008
570


Ex 121
Ref.
Dopant 1D
Host 2D-A
Ref.
3.85
5.13
0.1419
0.1040
352


Ex 122
Ref.
Dopant 1D
Host 2D-A
HBL1
3.85
6.16
0.1419
0.1040
587


Ex 123
Ref.
Dopant 1D
Host 2D-A
HBL2
3.70
6.50
0.1389
0.1020
470


Ex 124
EBL
Dopant 1D
Host 2D-A
Ref.
3.65
5.47
0.1389
0.1020
440


Ex 125
EBL
Dopant 1D
Host 2D-A
HBL1
3.65
6.84
0.1389
0.1020
734


Ex 126
EBL
Dopant 1D
Host 2D-A
HBL2
3.50
8.21
0.1389
0.1010
587


Ex 127
Ref.
Dopant 1D
Host 2D-P1
Ref.
3.82
5.12
0.1422
0.1042
203


Ex 128
Ref.
Dopant 1D
Host 2D-P1
HBL1
3.82
6.15
0.1422
0.1042
338


Ex 129
Ref.
Dopant 1D
Host 2D-P1
HBL2
3.67
6.49
0.1392
0.1022
270


Ex 130
EBL
Dopant 1D
Host 2D-P1
Ref.
3.62
5.46
0.1392
0.1022
253


Ex 131
EBL
Dopant 1D
Host 2D-P1
HBL1
3.62
6.83
0.1392
0.1022
422


Ex 132
EBL
Dopant 1D
Host 2D-P1
HBL2
3.47
8.20
0.1392
0.1012
338









TABLE 9














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 133
Ref.
Dopant 1D
Host 2D-P2
Ref.
3.83
5.12
0.1423
0.1038
203


Ex 134
Ref.
Dopant 1D
Host 2D-P2
HBL1
3.83
6.15
0.1423
0.1038
338


Ex 135
Ref.
Dopant 1D
Host 2D-P2
HBL2
3.68
6.49
0.1393
0.1018
270


Ex 136
EBL
Dopant 1D
Host 2D-P2
Ref.
3.63
5.46
0.1393
0.1018
253


Ex 137
EBL
Dopant 1D
Host 2D-P2
HBL1
3.63
6.83
0.1393
0.1018
422


Ex 138
EBL
Dopant 1D
Host 2D-P2
HBL2
3.48
8.20
0.1393
0.1008
338


Ex 139
Ref.
Dopant 1D-A
Host 2
Ref.
3.83
5.14
0.1416
0.1041
210


Ex 140
Ref.
Dopant 1D-A
Host 2
HBL1
3.83
6.17
0.1416
0.1041
350


Ex 141
Ref.
Dopant 1D-A
Host 2
HBL2
3.68
6.51
0.1386
0.1021
280


Ex 142
EBL
Dopant 1D-A
Host 2
Ref.
3.63
5.48
0.1386
0.1021
263


Ex 143
EBL
Dopant 1D-A
Host 2
HBL1
3.63
6.85
0.1386
0.1021
438


Ex 144
EBL
Dopant 1D-A
Host 2
HBL2
3.48
8.22
0.1386
0.1011
350


Ex 145
Ref.
Dopant 1D-A
Host 2D
Ref.
3.83
5.13
0.1424
0.1037
361


Ex 146
Ref.
Dopant 1D-A
Host 2D
HBL1
3.83
6.16
0.1424
0.1037
602


Ex 147
Ref.
Dopant 1D-A
Host 2D
HBL2
3.68
6.50
0.1394
0.1017
482


Ex 148
EBL
Dopant 1D-A
Host 2D
Ref.
3.63
5.47
0.1394
0.1017
452


Ex 149
EBL
Dopant 1D-A
Host 2D
HBL1
3.63
6.84
0.1394
0.1017
753


Ex 150
EBL
Dopant 1D-A
Host 2D
HBL2
3.48
8.21
0.1394
0.1007
602









TABLE 10














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 151
Ref.
Dopant 1D-A
Host 2D-A
Ref.
3.84
5.12
0.1417
0.1039
370


Ex 152
Ref.
Dopant 1D-A
Host 2D-A
HBL1
3.84
6.14
0.1417
0.1039
617


Ex 153
Ref.
Dopant 1D-A
Host 2D-A
HBL2
3.69
6.48
0.1387
0.1019
493


Ex 154
EBL
Dopant 1D-A
Host 2D-A
Ref.
3.64
5.46
0.1387
0.1019
463


Ex 155
EBL
Dopant 1D-A
Host 2D-A
HBL1
3.64
6.82
0.1387
0.1019
771


Ex 156
EBL
Dopant 1D-A
Host 2D-A
HBL2
3.49
8.18
0.1387
0.1009
617


Ex 157
Ref.
Dopant 1D-A
Host 2D-P1
Ref.
3.83
5.12
0.1422
0.1038
211


Ex 158
Ref.
Dopant 1D-A
Host 2D-P1
HBL1
3.83
6.15
0.1422
0.1038
352


Ex 159
Ref.
Dopant 1D-A
Host 2D-P1
HBL2
3.68
6.49
0.1392
0.1018
282


Ex 160
EBL
Dopant 1D-A
Host 2D-P1
Ref.
3.63
5.46
0.1392
0.1018
264


Ex 161
EBL
Dopant 1D-A
Host 2D-P1
HBL1
3.63
6.83
0.1392
0.1018
440


Ex 162
EBL
Dopant 1D-A
Host 2D-P1
HBL2
3.48
8.20
0.1392
0.1008
352


Ex 163
Ref.
Dopant 1D-A
Host 2D-P2
Ref.
3.84
5.13
0.1422
0.1039
210


Ex 164
Ref.
Dopant 1D-A
Host 2D-P2
HBL1
3.84
6.16
0.1422
0.1039
350


Ex 165
Ref.
Dopant 1D-A
Host 2D-P2
HBL2
3.69
6.50
0.1392
0.1019
280


Ex 166
EBL
Dopant 1D-A
Host 2D-P2
Ref.
3.64
5.47
0.1392
0.1019
263


Ex 167
EBL
Dopant 1D-A
Host 2D-P2
HBL1
3.64
6.84
0.1392
0.1019
438


Ex 168
EBL
Dopant 1D-A
Host 2D-P2
HBL2
3.49
8.21
0.1392
0.1009
350









TABLE 11














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ref 13.
Ref.
Dopant 1
Host 3
Ref.
3.74
4.91
0.1423
0.1052
135


Ref 14.
Ref.
Dopant 1
Host 3
HBL1
3.74
6.21
0.1423
0.1052
226


Ref 15.
Ref.
Dopant 1
Host 3
HBL2
3.59
6.21
0.1393
0.1032
180


Ref 16.
EBL
Dopant 1
Host 3
Ref.
3.54
5.23
0.1393
0.1032
169


Ref 17.
EBL
Dopant 1
Host 3
HBL1
3.54
6.54
0.1393
0.1032
282


Ref 18.
EBL
Dopant 1
Host 3
HBL2
3.39
7.85
0.1393
0.1022
226


Ex 169
Ref.
Dopant 1
Host 3D
Ref.
3.72
4.91
0.1420
0.1055
231


Ex 170
Ref.
Dopant 1
Host 3D
HBL1
3.72
6.22
0.1420
0.1055
386


Ex 171
Ref.
Dopant 1
Host 3D
HBL2
3.57
6.22
0.1390
0.1035
308


Ex 172
EBL
Dopant 1
Host 3D
Ref.
3.52
5.24
0.1390
0.1035
289


Ex 173
EBL
Dopant 1
Host 3D
HBL1
3.52
6.55
0.1390
0.1035
482


Ex 174
EBL
Dopant 1
Host 3D
HBL2
3.37
7.86
0.1390
0.1025
386


Ex 175
Ref.
Dopant 1
Host 3D-A
Ref.
3.70
4.88
0.1419
0.1045
238


Ex 176
Ref.
Dopant 1
Host 3D-A
HBL1
3.70
6.18
0.1419
0.1045
396


Ex 177
Ref.
Dopant 1
Host 3D-A
HBL2
3.55
6.18
0.1389
0.1025
317


Ex 178
EBL
Dopant 1
Host 3D-A
Ref.
3.50
5.20
0.1389
0.1025
297


Ex 179
EBL
Dopant 1
Host 3D-A
HBL1
3.50
6.50
0.1389
0.1025
495


Ex 180
EBL
Dopant 1
Host 3D-A
HBL2
3.35
7.80
0.1389
0.1015
396









TABLE 12














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 181
Ref.
Dopant 1
Host 3D-P1
Ref.
3.72
4.89
0.1420
0.1050
135


Ex 182
Ref.
Dopant 1
Host 3D-P1
HBL1
3.72
6.19
0.1420
0.1050
226


Ex 183
Ref.
Dopant 1
Host 3D-P1
HBL2
3.57
6.19
0.1390
0.1030
180


Ex 184
EBL
Dopant 1
Host 3D-P1
Ref.
3.52
5.22
0.1390
0.1030
169


Ex 185
EBL
Dopant 1
Host 3D-P1
HBL1
3.52
6.52
0.1390
0.1030
282


Ex 186
EBL
Dopant 1
Host 3D-P1
HBL2
3.37
7.82
0.1390
0.1020
226


Ex 187
Ref.
Dopant 1
Host 3D-P2
Ref.
3.74
4.89
0.1421
0.1051
135


Ex 188
Ref.
Dopant 1
Host 3D-P2
HBL1
3.74
6.19
0.1421
0.1051
225


Ex 189
Ref.
Dopant 1
Host 3D-P2
HBL2
3.59
6.19
0.1391
0.1031
180


Ex 190
EBL
Dopant 1
Host 3D-P2
Ref.
3.54
5.22
0.1391
0.1031
169


Ex 191
EBL
Dopant 1
Host 3D-P2
HBL1
3.54
6.52
0.1391
0.1031
281


Ex 192
EBL
Dopant 1
Host 3D-P2
HBL2
3.39
7.82
0.1391
0.1021
225


Ex 193
Ref.
Dopant 1D
Host 3
Ref.
3.74
4.90
0.1422
0.1053
180


Ex 194
Ref.
Dopant 1D
Host 3
HBL1
3.74
6.20
0.1422
0.1053
300


Ex 195
Ref.
Dopant 1D
Host 3
HBL2
3.59
6.20
0.1392
0.1033
240


Ex 196
EBL
Dopant 1D
Host 3
Ref.
3.54
5.22
0.1392
0.1033
225


Ex 197
EBL
Dopant 1D
Host 3
HBL1
3.54
6.53
0.1392
0.1033
375


Ex 198
EBL
Dopant 1D
Host 3
HBL2
3.39
7.84
0.1392
0.1023
300









TABLE 13














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 199
Ref.
Dopant 1D
Host 3D
Ref.
3.73
4.90
0.1421
0.1053
303


Ex 200
Ref.
Dopant 1D
Host 3D
HBL1
3.73
6.20
0.1421
0.1053
505


Ex 201
Ref.
Dopant 1D
Host 3D
HBL2
3.58
6.20
0.1391
0.1033
404


Ex 202
EBL
Dopant 1D
Host 3D
Ref.
3.53
5.22
0.1391
0.1033
379


Ex 203
EBL
Dopant 1D
Host 3D
HBL1
3.53
6.53
0.1391
0.1033
631


Ex 204
EBL
Dopant 1D
Host 3D
HBL2
3.38
7.84
0.1391
0.1023
505


Ex 205
Ref.
Dopant 1D
Host 3D-A
Ref.
3.75
4.91
0.1423
0.1048
315


Ex 206
Ref.
Dopant 1D
Host 3D-A
HBL1
3.75
6.22
0.1423
0.1048
525


Ex 207
Ref.
Dopant 1D
Host 3D-A
HBL2
3.60
6.22
0.1393
0.1028
420


Ex 208
EBL
Dopant 1D
Host 3D-A
Ref.
3.55
5.24
0.1393
0.1028
394


Ex 209
EBL
Dopant 1D
Host 3D-A
HBL1
3.55
6.55
0.1393
0.1028
656


Ex 210
EBL
Dopant 1D
Host 3D-A
HBL2
3.40
7.86
0.1393
0.1018
525


Ex 211
Ref.
Dopant 1D
Host 3D-P1
Ref.
3.70
4.88
0.1420
0.1048
180


Ex 212
Ref.
Dopant 1D
Host 3D-P1
HBL1
3.70
6.18
0.1420
0.1048
299


Ex 213
Ref.
Dopant 1D
Host 3D-P1
HBL2
3.55
6.18
0.1390
0.1028
239


Ex 214
EBL
Dopant 1D
Host 3D-P1
Ref.
3.50
5.21
0.1390
0.1028
224


Ex 215
EBL
Dopant 1D
Host 3D-P1
HBL1
3.50
6.51
0.1390
0.1028
374


Ex 216
EBL
Dopant 1D
Host 3D-P1
HBL2
3.35
7.81
0.1390
0.1018
299









TABLE 14














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 217
Ref.
Dopant 1D
Host 3D-P2
Ref.
3.76
4.88
0.1421
0.1052
180


Ex 218
Ref.
Dopant 1D
Host 3D-P2
HBL1
3.76
6.18
0.1421
0.1052
300


Ex 219
Ref.
Dopant 1D
Host 3D-P2
HBL2
3.61
6.18
0.1391
0.1032
240


Ex 220
EBL
Dopant 1D
Host 3D-P2
Ref.
3.56
5.20
0.1391
0.1032
225


Ex 221
EBL
Dopant 1D
Host 3D-P2
HBL1
3.56
6.50
0.1391
0.1032
375


Ex 222
EBL
Dopant 1D
Host 3D-P2
HBL2
3.41
7.80
0.1391
0.1022
300


Ex 223
Ref.
Dopant 1D-A
Host 3
Ref.
3.72
4.92
0.1418
0.1051
183


Ex 224
Ref.
Dopant 1D-A
Host 3
HBL1
3.72
6.23
0.1418
0.1051
305


Ex 225
Ref.
Dopant 1D-A
Host 3
HBL2
3.57
6.23
0.1388
0.1031
244


Ex 226
EBL
Dopant 1D-A
Host 3
Ref.
3.52
5.25
0.1388
0.1031
229


Ex 227
EBL
Dopant 1D-A
Host 3
HBL1
3.52
6.56
0.1388
0.1031
381


Ex 228
EBL
Dopant 1D-A
Host 3
HBL2
3.37
7.87
0.1388
0.1021
305


Ex 229
Ref.
Dopant 1D-A
Host 3D
Ref.
3.72
4.91
0.1422
0.1052
327


Ex 230
Ref.
Dopant 1D-A
Host 3D
HBL1
3.72
6.21
0.1422
0.1052
545


Ex 231
Ref.
Dopant 1D-A
Host 3D
HBL2
3.57
6.21
0.1392
0.1032
436


Ex 232
EBL
Dopant 1D-A
Host 3D
Ref.
3.52
5.23
0.1392
0.1032
409


Ex 233
EBL
Dopant 1D-A
Host 3D
HBL1
3.52
6.54
0.1392
0.1032
681


Ex 234
EBL
Dopant 1D-A
Host 3D
HBL2
3.37
7.85
0.1392
0.1022
545









TABLE 15














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 235
Ref.
Dopant 1D-A
Host 3D-A
Ref.
3.73
4.91
0.1420
0.1052
329


Ex 236
Ref.
Dopant 1D-A
Host 3D-A
HBL1
3.73
6.21
0.1420
0.1052
549


Ex 237
Ref.
Dopant 1D-A
Host 3D-A
HBL2
3.58
6.21
0.1390
0.1032
439


Ex 238
EBL
Dopant 1D-A
Host 3D-A
Ref.
3.53
5.23
0.1390
0.1032
412


Ex 239
EBL
Dopant 1D-A
Host 3D-A
HBL1
3.53
6.54
0.1390
0.1032
686


Ex 240
EBL
Dopant 1D-A
Host 3D-A
HBL2
3.38
7.85
0.1390
0.1022
549


Ex 241
Ref.
Dopant 1D-A
Host 3D-P1
Ref.
3.72
4.90
0.1422
0.1050
183


Ex 242
Ref.
Dopant 1D-A
Host 3D-P1
HBL1
3.72
6.20
0.1422
0.1050
305


Ex 243
Ref.
Dopant 1D-A
Host 3D-P1
HBL2
3.57
6.20
0.1392
0.1030
244


Ex 244
EBL
Dopant 1D-A
Host 3D-P1
Ref.
3.52
5.22
0.1392
0.1030
229


Ex 245
EBL
Dopant 1D-A
Host 3D-P1
HBL1
3.52
6.53
0.1392
0.1030
381


Ex 246
EBL
Dopant 1D-A
Host 3D-P1
HBL2
3.37
7.84
0.1392
0.1020
305


Ex 247
Ref.
Dopant 1D-A
Host 3D-P2
Ref.
3.74
4.88
0.1421
0.1051
183


Ex 248
Ref.
Dopant 1D-A
Host 3D-P2
HBL1
3.74
6.18
0.1421
0.1051
305


Ex 249
Ref.
Dopant 1D-A
Host 3D-P2
HBL2
3.59
6.18
0.1391
0.1031
244


Ex 250
EBL
Dopant 1D-A
Host 3D-P2
Ref.
3.54
5.21
0.1391
0.1031
229


Ex 251
EBL
Dopant 1D-A
Host 3D-P2
HBL1
3.54
6.51
0.1391
0.1031
381


Ex 252
EBL
Dopant 1D-A
Host 3D-P2
HBL2
3.39
7.81
0.1391
0.1021
305









TABLE 16














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ref 19
Ref.
Dopant 1
Host 4
Ref.
3.79
4.95
0.1423
0.1049
139


Ref 20
Ref.
Dopant 1
Host 4
HBL1
3.79
5.94
0.1423
0.1049
232


Ref 21
Ref.
Dopant 1
Host 4
HBL2
3.64
6.27
0.1393
0.1029
186


Ref 22
EBL
Dopant 1
Host 4
Ref.
3.59
5.28
0.1393
0.1029
174


Ref 23
EBL
Dopant 1
Host 4
HBL1
3.59
6.60
0.1393
0.1029
290


Ref 24
EBL
Dopant 1
Host 4
HBL2
3.44
7.92
0.1393
0.1019
232


Ex 253
Ref.
Dopant 1
Host 4D
Ref.
3.80
4.97
0.1423
0.1050
241


Ex 254
Ref.
Dopant 1
Host 4D
HBL1
3.80
5.96
0.1423
0.1050
402


Ex 255
Ref.
Dopant 1
Host 4D
HBL2
3.65
6.29
0.1393
0.1030
321


Ex 256
EBL
Dopant 1
Host 4D
Ref.
3.60
5.30
0.1393
0.1030
301


Ex 257
EBL
Dopant 1
Host 4D
HBL1
3.60
6.62
0.1393
0.1030
502


Ex 258
EBL
Dopant 1
Host 4D
HBL2
3.45
7.94
0.1393
0.1020
402


Ex 259
Ref.
Dopant 1
Host 4D-A
Ref.
3.78
4.93
0.1410
0.1044
248


Ex 260
Ref.
Dopant 1
Host 4D-A
HBL1
3.78
5.91
0.1410
0.1044
413


Ex 261
Ref.
Dopant 1
Host 4D-A
HBL2
3.63
6.24
0.1380
0.1024
330


Ex 262
EBL
Dopant 1
Host 4D-A
Ref.
3.58
5.26
0.1380
0.1024
310


Ex 263
EBL
Dopant 1
Host 4D-A
HBL1
3.58
6.57
0.1380
0.1024
516


Ex 264
EBL
Dopant 1
Host 4D-A
HBL2
3.43
7.88
0.1380
0.1014
413









TABLE 17














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 265
Ref.
Dopant 1
Host 4D-P1
Ref.
3.82
4.99
0.1421
0.1049
140


Ex 266
Ref.
Dopant 1
Host 4D-P1
HBL1
3.82
5.99
0.1421
0.1049
233


Ex 267
Ref.
Dopant 1
Host 4D-P1
HBL2
3.67
6.32
0.1391
0.1029
186


Ex 268
EBL
Dopant 1
Host 4D-P1
Ref.
3.62
5.32
0.1391
0.1029
175


Ex 269
EBL
Dopant 1
Host 4D-P1
HBL1
3.62
6.65
0.1391
0.1029
291


Ex 270
EBL
Dopant 1
Host 4D-P1
HBL2
3.47
7.98
0.1391
0.1019
233


Ex 271
Ref.
Dopant 1
Host 4D-P2
Ref.
3.80
4.95
0.1428
0.1055
140


Ex 272
Ref.
Dopant 1
Host 4D-P2
HBL1
3.80
5.94
0.1428
0.1055
233


Ex 273
Ref.
Dopant 1
Host 4D-P2
HBL2
3.65
6.27
0.1398
0.1035
186


Ex 274
EBL
Dopant 1
Host 4D-P2
Ref.
3.60
5.28
0.1398
0.1035
175


Ex 275
EBL
Dopant 1
Host 4D-P2
HBL1
3.60
6.60
0.1398
0.1035
291


Ex 276
EBL
Dopant 1
Host 4D-P2
HBL2
3.45
7.92
0.1398
0.1025
233


Ex 277
Ref.
Dopant 1D
Host 4
Ref.
3.79
4.95
0.1421
0.1050
184


Ex 278
Ref.
Dopant 1D
Host 4
HBL1
3.79
5.94
0.1421
0.1050
306


Ex 279
Ref.
Dopant 1D
Host 4
HBL2
3.64
6.27
0.1391
0.1030
245


Ex 280
EBL
Dopant 1D
Host 4
Ref.
3.59
5.28
0.1391
0.1030
230


Ex 281
EBL
Dopant 1D
Host 4
HBL1
3.59
6.60
0.1391
0.1030
383


Ex 282
EBL
Dopant 1D
Host 4
HBL2
3.44
7.92
0.1391
0.1020
306









TABLE 18














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 283
Ref.
Dopant 1D
Host 4D
Ref.
3.80
4.96
0.1420
0.1050
314


Ex 284
Ref.
Dopant 1D
Host 4D
HBL1
3.80
5.95
0.1420
0.1050
523


Ex 285
Ref.
Dopant 1D
Host 4D
HBL2
3.65
6.28
0.1390
0.1030
419


Ex 286
EBL
Dopant 1D
Host 4D
Ref.
3.60
5.29
0.1390
0.1030
392


Ex 287
EBL
Dopant 1D
Host 4D
HBL1
3.60
6.61
0.1390
0.1030
654


Ex 288
EBL
Dopant 1D
Host 4D
HBL2
3.45
7.93
0.1390
0.1020
523


Ex 289
Ref.
Dopant 1D
Host 4D-A
Ref.
3.79
4.96
0.1425
0.1055
325


Ex 290
Ref.
Dopant 1D
Host 4D-A
HBL1
3.79
5.95
0.1425
0.1055
542


Ex 291
Ref.
Dopant 1D
Host 4D-A
HBL2
3.64
6.28
0.1395
0.1035
434


Ex 292
EBL
Dopant 1D
Host 4D-A
Ref.
3.59
5.29
0.1395
0.1035
407


Ex 293
EBL
Dopant 1D
Host 4D-A
HBL1
3.59
6.61
0.1395
0.1035
678


Ex 294
EBL
Dopant 1D
Host 4D-A
HBL2
3.44
7.93
0.1395
0.1025
542


Ex 295
Ref.
Dopant 1D
Host 4D-P1
Ref.
3.79
4.91
0.1422
0.1052
184


Ex 296
Ref.
Dopant 1D
Host 4D-P1
HBL1
3.79
5.89
0.1422
0.1052
306


Ex 297
Ref.
Dopant 1D
Host 4D-P1
HBL2
3.64
6.21
0.1392
0.1032
245


Ex 298
EBL
Dopant 1D
Host 4D-P1
Ref.
3.59
5.23
0.1392
0.1032
230


Ex 299
EBL
Dopant 1D
Host 4D-P1
HBL1
3.59
6.54
0.1392
0.1032
383


Ex 300
EBL
Dopant 1D
Host 4D-P1
HBL2
3.44
7.85
0.1392
0.1022
306









TABLE 19














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 301
Ref.
Dopant 1D
Host 4D-P2
Ref.
3.77
4.94
0.1412
0.1050
183


Ex 302
Ref.
Dopant 1D
Host 4D-P2
HBL1
3.77
5.92
0.1412
0.1050
305


Ex 303
Ref.
Dopant 1D
Host 4D-P2
HBL2
3.62
6.25
0.1382
0.1030
244


Ex 304
EBL
Dopant 1D
Host 4D-P2
Ref.
3.57
5.26
0.1382
0.1030
229


Ex 305
EBL
Dopant 1D
Host 4D-P2
HBL1
3.57
6.58
0.1382
0.1030
381


Ex 306
EBL
Dopant 1D
Host 4D-P2
HBL2
3.42
7.90
0.1382
0.1020
305


Ex 307
Ref.
Dopant 1D-A
Host 4
Ref.
3.79
4.95
0.1420
0.1052
188


Ex 308
Ref.
Dopant 1D-A
Host 4
HBL1
3.79
5.94
0.1420
0.1052
314


Ex 309
Ref.
Dopant 1D-A
Host 4
HBL2
3.64
6.27
0.1390
0.1032
251


Ex 310
EBL
Dopant 1D-A
Host 4
Ref.
3.59
5.28
0.1390
0.1032
235


Ex 311
EBL
Dopant 1D-A
Host 4
HBL1
3.59
6.60
0.1390
0.1032
392


Ex 312
EBL
Dopant 1D-A
Host 4
HBL2
3.44
7.92
0.1390
0.1022
314


Ex 313
Ref.
Dopant 1D-A
Host 4D
Ref.
3.80
4.95
0.1420
0.1051
331


Ex 314
Ref.
Dopant 1D-A
Host 4D
HBL1
3.80
5.94
0.1420
0.1051
552


Ex 315
Ref.
Dopant 1D-A
Host 4D
HBL2
3.65
6.27
0.1390
0.1031
442


Ex 316
EBL
Dopant 1D-A
Host 4D
Ref.
3.60
5.28
0.1390
0.1031
414


Ex 317
EBL
Dopant 1D-A
Host 4D
HBL1
3.60
6.60
0.1390
0.1031
690


Ex 318
EBL
Dopant 1D-A
Host 4D
HBL2
3.45
7.92
0.1390
0.1021
552









TABLE 20














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 319
Ref.
Dopant 1D-A
Host 4D-A
Ref.
3.84
5.00
0.1418
0.1053
339


Ex 320
Ref.
Dopant 1D-A
Host 4D-A
HBL1
3.84
6.00
0.1418
0.1053
565


Ex 321
Ref.
Dopant 1D-A
Host 4D-A
HBL2
3.69
6.34
0.1388
0.1033
452


Ex 322
EBL
Dopant 1D-A
Host 4D-A
Ref.
3.64
5.34
0.1388
0.1033
424


Ex 323
EBL
Dopant 1D-A
Host 4D-A
HBL1
3.64
6.67
0.1388
0.1033
706


Ex 324
EBL
Dopant 1D-A
Host 4D-A
HBL2
3.49
8.00
0.1388
0.1023
565


Ex 325
Ref.
Dopant 1D-A
Host 4D-P1
Ref.
3.83
4.95
0.1420
0.1050
188


Ex 326
Ref.
Dopant 1D-A
Host 4D-P1
HBL1
3.83
5.94
0.1420
0.1050
314


Ex 327
Ref.
Dopant 1D-A
Host 4D-P1
HBL2
3.68
6.27
0.1390
0.1030
251


Ex 328
EBL
Dopant 1D-A
Host 4D-P1
Ref.
3.63
5.28
0.1390
0.1030
235


Ex 329
EBL
Dopant 1D-A
Host 4D-P1
HBL1
3.63
6.60
0.1390
0.1030
392


Ex 330
EBL
Dopant 1D-A
Host 4D-P1
HBL2
3.48
7.92
0.1390
0.1020
314


Ex 331
Ref.
Dopant 1D-A
Host 4D-P2
Ref.
6.82
4.94
0.1421
0.1047
188


Ex 332
Ref.
Dopant 1D-A
Host 4D-P2
HBL1
6.82
5.92
0.1421
0.1047
314


Ex 333
Ref.
Dopant 1D-A
Host 4D-P2
HBL2
6.67
6.25
0.1391
0.1027
251


Ex 334
EBL
Dopant 1D-A
Host 4D-P2
Ref.
6.62
5.26
0.1391
0.1027
235


Ex 335
EBL
Dopant 1D-A
Host 4D-P2
HBL1
6.62
6.58
0.1391
0.1027
392


Ex 336
EBL
Dopant 1D-A
Host 4D-P2
HBL2
6.47
7.90
0.1391
0.1017
314









TABLE 21














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ref 25
Ref.
Dopant 2
Host 1
Ref.
3.95
5.05
0.1410
0.1030
185


Ref 26
Ref.
Dopant 2
Host 1
HBL1
3.95
6.06
0.1410
0.1030
308


Ref 27
Ref.
Dopant 2
Host 1
HBL2
3.80
6.39
0.1380
0.1010
246


Ref 28
EBL
Dopant 2
Host 1
Ref.
3.75
5.38
0.1380
0.1010
231


Ref 29
EBL
Dopant 2
Host 1
HBL1
3.75
6.73
0.1380
0.1010
385


Ref 30
EBL
Dopant 2
Host 1
HBL2
3.60
8.08
0.1380
0.1000
308


Ex 337
Ref.
Dopant 2
Host 1D
Ref.
3.95
5.05
0.1411
0.1030
316


Ex 338
Ref.
Dopant 2
Host 1D
HBL1
3.95
6.06
0.1411
0.1030
526


Ex 339
Ref.
Dopant 2
Host 1D
HBL2
3.80
6.39
0.1381
0.1010
421


Ex 340
EBL
Dopant 2
Host 1D
Ref.
3.75
5.38
0.1381
0.1010
395


Ex 341
EBL
Dopant 2
Host 1D
HBL1
3.75
6.73
0.1381
0.1010
658


Ex 342
EBL
Dopant 2
Host 1D
HBL2
3.60
8.08
0.1381
0.1000
526


Ex 343
Ref.
Dopant 2
Host 1D-A
Ref.
3.90
5.03
0.1412
0.1035
322


Ex 344
Ref.
Dopant 2
Host 1D-A
HBL1
3.90
6.04
0.1412
0.1035
536


Ex 345
Ref.
Dopant 2
Host 1D-A
HBL2
3.75
6.37
0.1382
0.1015
429


Ex 346
EBL
Dopant 2
Host 1D-A
Ref.
3.70
5.37
0.1382
0.1015
402


Ex 347
EBL
Dopant 2
Host 1D-A
HBL1
3.70
6.71
0.1382
0.1015
670


Ex 348
EBL
Dopant 2
Host 1D-A
HBL2
3.55
8.05
0.1382
0.1005
536









TABLE 22














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 349
Ref.
Dopant 2
Host 1D-P1
Ref.
3.95
5.04
0.1412
0.1029
185


Ex 350
Ref.
Dopant 2
Host 1D-P1
HBL1
3.95
6.05
0.1412
0.1029
308


Ex 351
Ref.
Dopant 2
Host 1D-P1
HBL2
3.80
6.38
0.1382
0.1009
246


Ex 352
EBL
Dopant 2
Host 1D-P1
Ref.
3.75
5.38
0.1382
0.1009
231


Ex 353
EBL
Dopant 2
Host 1D-P1
HBL1
3.75
6.72
0.1382
0.1009
385


Ex 354
EBL
Dopant 2
Host 1D-P1
HBL2
3.60
8.06
0.1382
0.0999
308


Ex 355
Ref.
Dopant 2
Host 1D-P2
Ref.
3.92
5.03
0.1411
0.1032
185


Ex 356
Ref.
Dopant 2
Host 1D-P2
HBL1
3.92
6.03
0.1411
0.1032
308


Ex 357
Ref.
Dopant 2
Host 1D-P2
HBL2
3.77
6.37
0.1381
0.1012
246


Ex 358
EBL
Dopant 2
Host 1D-P2
Ref.
3.72
5.36
0.1381
0.1012
231


Ex 359
EBL
Dopant 2
Host 1D-P2
HBL1
3.72
6.70
0.1381
0.1012
385


Ex 360
EBL
Dopant 2
Host 1D-P2
HBL2
3.57
8.04
0.1381
0.1002
308


Ex 361
Ref.
Dopant 2D
Host 1
Ref.
3.96
5.04
0.1412
0.1028
240


Ex 362
Ref.
Dopant 2D
Host 1
HBL1
3.96
6.05
0.1412
0.1028
400


Ex 363
Ref.
Dopant 2D
Host 1
HBL2
3.81
6.38
0.1382
0.1008
320


Ex 364
EBL
Dopant 2D
Host 1
Ref.
3.76
5.38
0.1382
0.1008
300


Ex 365
EBL
Dopant 2D
Host 1
HBL1
3.76
6.72
0.1382
0.1008
500


Ex 366
EBL
Dopant 2D
Host 1
HBL2
3.61
8.06
0.1382
0.0998
400









TABLE 23














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 367
Ref.
Dopant 2D
Host 1D
Ref.
3.96
5.03
0.1412
0.1032
403


Ex 368
Ref.
Dopant 2D
Host 1D
HBL1
3.96
6.04
0.1412
0.1032
671


Ex 369
Ref.
Dopant 2D
Host 1D
HBL2
3.81
6.37
0.1382
0.1012
537


Ex 370
EBL
Dopant 2D
Host 1D
Ref.
3.76
5.37
0.1382
0.1012
503


Ex 371
EBL
Dopant 2D
Host 1D
HBL1
3.76
6.71
0.1382
0.1012
839


Ex 372
EBL
Dopant 2D
Host 1D
HBL2
3.61
8.05
0.1382
0.1002
671


Ex 373
Ref.
Dopant 2D
Host 1D-A
Ref.
3.91
5.10
0.1408
0.1033
421


Ex 374
Ref.
Dopant 2D
Host 1D-A
HBL1
3.91
6.12
0.1408
0.1033
702


Ex 375
Ref.
Dopant 2D
Host 1D-A
HBL2
3.76
6.46
0.1378
0.1013
561


Ex 376
EBL
Dopant 2D
Host 1D-A
Ref.
3.71
5.44
0.1378
0.1013
526


Ex 377
EBL
Dopant 2D
Host 1D-A
HBL1
3.71
6.80
0.1378
0.1013
877


Ex 378
EBL
Dopant 2D
Host 1D-A
HBL2
3.56
8.16
0.1378
0.1003
702


Ex 379
Ref.
Dopant 2D
Host 1D-P1
Ref.
3.94
5.04
0.1412
0.1027
240


Ex 380
Ref.
Dopant 2D
Host 1D-P1
HBL1
3.94
6.05
0.1412
0.1027
400


Ex 381
Ref.
Dopant 2D
Host 1D-P1
HBL2
3.79
6.38
0.1382
0.1007
320


Ex 382
EBL
Dopant 2D
Host 1D-P1
Ref.
3.74
5.38
0.1382
0.1007
300


Ex 383
EBL
Dopant 2D
Host 1D-P1
HBL1
3.74
6.72
0.1382
0.1007
500


Ex 384
EBL
Dopant 2D
Host 1D-P1
HBL2
3.59
8.06
0.1382
0.0997
400









TABLE 24














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 385
Ref.
Dopant 2D
Host 1D-P2
Ref.
3.95
5.01
0.1411
0.1034
240


Ex 386
Ref.
Dopant 2D
Host 1D-P2
HBL1
3.95
6.01
0.1411
0.1034
401


Ex 387
Ref.
Dopant 2D
Host 1D-P2
HBL2
3.80
6.35
0.1381
0.1014
321


Ex 388
EBL
Dopant 2D
Host 1D-P2
Ref.
3.75
5.34
0.1381
0.1014
301


Ex 389
EBL
Dopant 2D
Host 1D-P2
HBL1
3.75
6.68
0.1381
0.1014
501


Ex 390
EBL
Dopant 2D
Host 1D-P2
HBL2
3.60
8.02
0.1381
0.1004
401


Ex 391
Ref.
Dopant 2D-A
Host 1
Ref.
3.98
5.03
0.1408
0.1033
252


Ex 392
Ref.
Dopant 2D-A
Host 1
HBL1
3.98
6.03
0.1408
0.1033
419


Ex 393
Ref.
Dopant 2D-A
Host 1
HBL2
3.83
6.37
0.1378
0.1013
335


Ex 394
EBL
Dopant 2D-A
Host 1
Ref.
3.78
5.36
0.1378
0.1013
314


Ex 395
EBL
Dopant 2D-A
Host 1
HBL1
3.78
6.70
0.1378
0.1013
524


Ex 396
EBL
Dopant 2D-A
Host 1
HBL2
3.63
8.04
0.1378
0.1003
419


Ex 397
Ref.
Dopant 2D-A
Host 1D
Ref.
3.97
5.03
0.1412
0.1033
422


Ex 398
Ref.
Dopant 2D-A
Host 1D
HBL1
3.97
6.03
0.1412
0.1033
704


Ex 399
Ref.
Dopant 2D-A
Host 1D
HBL2
3.82
6.37
0.1382
0.1013
563


Ex 400
EBL
Dopant 2D-A
Host 1D
Ref.
3.77
5.36
0.1382
0.1013
528


Ex 401
EBL
Dopant 2D-A
Host 1D
HBL1
3.77
6.70
0.1382
0.1013
880


Ex 402
EBL
Dopant 2D-A
Host 1D
HBL2
3.62
8.04
0.1382
0.1003
704









TABLE 25














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 403
Ref.
Dopant 2D-A
Host 1D-A
Ref.
3.91
5.04
0.1413
0.1030
432


Ex 404
Ref.
Dopant 2D-A
Host 1D-A
HBL1
3.91
6.05
0.1413
0.1030
721


Ex 405
Ref.
Dopant 2D-A
Host 1D-A
HBL2
3.76
6.38
0.1383
0.1010
577


Ex 406
EBL
Dopant 2D-A
Host 1D-A
Ref.
3.71
5.38
0.1383
0.1010
541


Ex 407
EBL
Dopant 2D-A
Host 1D-A
HBL1
3.71
6.72
0.1383
0.1010
901


Ex 408
EBL
Dopant 2D-A
Host 1D-A
HBL2
3.56
8.06
0.1383
0.1000
721


Ex 409
Ref.
Dopant 2D-A
Host 1D-P1
Ref.
3.92
5.03
0.1412
0.1031
252


Ex 410
Ref.
Dopant 2D-A
Host 1D-P1
HBL1
3.92
6.04
0.1412
0.1031
420


Ex 411
Ref.
Dopant 2D-A
Host 1D-P1
HBL2
3.77
6.37
0.1382
0.1011
336


Ex 412
EBL
Dopant 2D-A
Host 1D-P1
Ref.
3.72
5.37
0.1382
0.1011
315


Ex 413
EBL
Dopant 2D-A
Host 1D-P1
HBL1
3.72
6.71
0.1382
0.1011
525


Ex 414
EBL
Dopant 2D-A
Host 1D-P1
HBL2
3.57
8.05
0.1382
0.1001
420


Ex 415
Ref.
Dopant 2D-A
Host 1D-P2
Ref.
3.95
5.00
0.1410
0.1032
252


Ex 416
Ref.
Dopant 2D-A
Host 1D-P2
HBL1
3.95
5.99
0.1410
0.1032
420


Ex 417
Ref.
Dopant 2D-A
Host 1D-P2
HBL2
3.80
6.33
0.1380
0.1012
336


Ex 418
EBL
Dopant 2D-A
Host 1D-P2
Ref.
3.75
5.33
0.1380
0.1012
315


Ex 419
EBL
Dopant 2D-A
Host 1D-P2
HBL1
3.75
6.66
0.1380
0.1012
525


Ex 420
EBL
Dopant 2D-A
Host 1D-P2
HBL2
3.60
7.99
0.1380
0.1002
420









TABLE 26














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ref 31
Ref.
Dopant 2
Host 2
Ref.
3.80
5.18
0.1411
0.1041
185


Ref 32
Ref.
Dopant 2
Host 2
HBL1
3.80
6.22
0.1411
0.1041
308


Ref 33
Ref.
Dopant 2
Host 2
HBL2
3.65
6.56
0.1381
0.1021
246


Ref 34
EBL
Dopant 2
Host 2
Ref.
3.60
5.53
0.1381
0.1021
231


Ref 35
EBL
Dopant 2
Host 2
HBL1
3.60
6.91
0.1381
0.1021
385


Ref 36
EBL
Dopant 2
Host 2
HBL2
3.45
8.29
0.1381
0.1011
308


Ex 421
Ref.
Dopant 2
Host 2D
Ref.
3.80
5.19
0.1413
0.1043
317


Ex 422
Ref.
Dopant 2
Host 2D
HBL1
3.80
6.23
0.1413
0.1043
528


Ex 423
Ref.
Dopant 2
Host 2D
HBL2
3.65
6.57
0.1383
0.1023
422


Ex 424
EBL
Dopant 2
Host 2D
Ref.
3.60
5.54
0.1383
0.1023
396


Ex 425
EBL
Dopant 2
Host 2D
HBL1
3.60
6.92
0.1383
0.1023
660


Ex 426
EBL
Dopant 2
Host 2D
HBL2
3.45
8.30
0.1383
0.1013
528


Ex 427
Ref.
Dopant 2
Host 2D-A
Ref.
3.75
5.14
0.1411
0.1042
324


Ex 428
Ref.
Dopant 2
Host 2D-A
HBL1
3.75
6.17
0.1411
0.1042
539


Ex 429
Ref.
Dopant 2
Host 2D-A
HBL2
3.60
6.51
0.1381
0.1022
431


Ex 430
EBL
Dopant 2
Host 2D-A
Ref.
3.55
5.48
0.1381
0.1022
404


Ex 431
EBL
Dopant 2
Host 2D-A
HBL1
3.55
6.85
0.1381
0.1022
674


Ex 432
EBL
Dopant 2
Host 2D-A
HBL2
3.40
8.22
0.1381
0.1012
539









TABLE 27














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 433
Ref.
Dopant 2
Host 2D-P1
Ref.
3.78
5.18
0.1412
0.1039
184


Ex 434
Ref.
Dopant 2
Host 2D-P1
HBL1
3.78
6.21
0.1412
0.1039
307


Ex 435
Ref.
Dopant 2
Host 2D-P1
HBL2
3.63
6.56
0.1382
0.1019
246


Ex 436
EBL
Dopant 2
Host 2D-P1
Ref.
3.58
5.52
0.1382
0.1019
230


Ex 437
EBL
Dopant 2
Host 2D-P1
HBL1
3.58
6.90
0.1382
0.1019
384


Ex 438
EBL
Dopant 2
Host 2D-P1
HBL2
3.43
8.28
0.1382
0.1009
307


Ex 439
Ref.
Dopant 2
Host 2D-P2
Ref.
3.78
5.16
0.1412
0.1042
185


Ex 440
Ref.
Dopant 2
Host 2D-P2
HBL1
3.78
6.19
0.1412
0.1042
309


Ex 441
Ref.
Dopant 2
Host 2D-P2
HBL2
3.63
6.54
0.1382
0.1022
247


Ex 442
EBL
Dopant 2
Host 2D-P2
Ref.
3.58
5.50
0.1382
0.1022
232


Ex 443
EBL
Dopant 2
Host 2D-P2
HBL1
3.58
6.88
0.1382
0.1022
386


Ex 444
EBL
Dopant 2
Host 2D-P2
HBL2
3.43
8.26
0.1382
0.1012
309


Ex 445
Ref.
Dopant 2D
Host 2
Ref.
3.79
5.18
0.1410
0.1044
241


Ex 446
Ref.
Dopant 2D
Host 2
HBL1
3.79
6.22
0.1410
0.1044
402


Ex 447
Ref.
Dopant 2D
Host 2
HBL2
3.64
6.56
0.1380
0.1024
321


Ex 448
EBL
Dopant 2D
Host 2
Ref.
3.59
5.53
0.1380
0.1024
301


Ex 449
EBL
Dopant 2D
Host 2
HBL1
3.59
6.91
0.1380
0.1024
502


Ex 450
EBL
Dopant 2D
Host 2
HBL2
3.44
8.29
0.1380
0.1014
402









TABLE 28














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 451
Ref.
Dopant 2D
Host 2D
Ref.
3.80
5.18
0.1411
0.1043
406


Ex 452
Ref.
Dopant 2D
Host 2D
HBL1
3.80
6.21
0.1411
0.1043
676


Ex 453
Ref.
Dopant 2D
Host 2D
HBL2
3.65
6.56
0.1381
0.1023
541


Ex 454
EBL
Dopant 2D
Host 2D
Ref.
3.60
5.52
0.1381
0.1023
507


Ex 455
EBL
Dopant 2D
Host 2D
HBL1
3.60
6.90
0.1381
0.1023
845


Ex 456
EBL
Dopant 2D
Host 2D
HBL2
3.45
8.28
0.1381
0.1013
676


Ex 457
Ref.
Dopant 2D
Host 2D-A
Ref.
3.78
5.19
0.1407
0.1042
422


Ex 458
Ref.
Dopant 2D
Host 2D-A
HBL1
3.78
6.23
0.1407
0.1042
703


Ex 459
Ref.
Dopant 2D
Host 2D-A
HBL2
3.63
6.57
0.1377
0.1022
563


Ex 460
EBL
Dopant 2D
Host 2D-A
Ref.
3.58
5.54
0.1377
0.1022
527


Ex 461
EBL
Dopant 2D
Host 2D-A
HBL1
3.58
6.92
0.1377
0.1022
879


Ex 462
EBL
Dopant 2D
Host 2D-A
HBL2
3.43
8.30
0.1377
0.1012
703


Ex 463
Ref.
Dopant 2D
Host 2D-P1
Ref.
3.82
5.13
0.1412
0.1039
241


Ex 464
Ref.
Dopant 2D
Host 2D-P1
HBL1
3.82
6.16
0.1412
0.1039
402


Ex 465
Ref.
Dopant 2D
Host 2D-P1
HBL2
3.67
6.50
0.1382
0.1019
321


Ex 466
EBL
Dopant 2D
Host 2D-P1
Ref.
3.62
5.47
0.1382
0.1019
301


Ex 467
EBL
Dopant 2D
Host 2D-P1
HBL1
3.62
6.84
0.1382
0.1019
502


Ex 468
EBL
Dopant 2D
Host 2D-P1
HBL2
3.47
8.21
0.1382
0.1009
402









TABLE 29














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 469
Ref.
Dopant 2D
Host 2D-P2
Ref.
3.76
5.15
0.1413
0.1040
240


Ex 470
Ref.
Dopant 2D
Host 2D-P2
HBL1
3.76
6.18
0.1413
0.1040
401


Ex 471
Ref.
Dopant 2D
Host 2D-P2
HBL2
3.61
6.53
0.1383
0.1020
321


Ex 472
EBL
Dopant 2D
Host 2D-P2
Ref.
3.56
5.50
0.1383
0.1020
301


Ex 473
EBL
Dopant 2D
Host 2D-P2
HBL1
3.56
6.87
0.1383
0.1020
501


Ex 474
EBL
Dopant 2D
Host 2D-P2
HBL2
3.41
8.24
0.1383
0.1010
401


Ex 475
Ref.
Dopant 2D-A
Host 2
Ref.
3.75
5.18
0.1410
0.1040
250


Ex 476
Ref.
Dopant 2D-A
Host 2
HBL1
3.75
6.21
0.1410
0.1040
416


Ex 477
Ref.
Dopant 2D-A
Host 2
HBL2
3.60
6.56
0.1380
0.1020
333


Ex 478
EBL
Dopant 2D-A
Host 2
Ref.
3.55
5.52
0.1380
0.1020
312


Ex 479
EBL
Dopant 2D-A
Host 2
HBL1
3.55
6.90
0.1380
0.1020
520


Ex 480
EBL
Dopant 2D-A
Host 2
HBL2
3.40
8.28
0.1380
0.1010
416


Ex 481
Ref.
Dopant 2D-A
Host 2D
Ref.
3.81
5.18
0.1411
0.1043
432


Ex 482
Ref.
Dopant 2D-A
Host 2D
HBL1
3.81
6.22
0.1411
0.1043
719


Ex 483
Ref.
Dopant 2D-A
Host 2D
HBL2
3.66
6.56
0.1381
0.1023
575


Ex 484
EBL
Dopant 2D-A
Host 2D
Ref.
3.61
5.53
0.1381
0.1023
539


Ex 485
EBL
Dopant 2D-A
Host 2D
HBL1
3.61
6.91
0.1381
0.1023
899


Ex 486
EBL
Dopant 2D-A
Host 2D
HBL2
3.46
8.29
0.1381
0.1013
719









TABLE 30














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 487
Ref.
Dopant 2D-A
Host 2D-A
Ref.
3.82
5.16
0.1412
0.1041
442


Ex 488
Ref.
Dopant 2D-A
Host 2D-A
HBL1
3.82
6.19
0.1412
0.1041
736


Ex 489
Ref.
Dopant 2D-A
Host 2D-A
HBL2
3.67
6.54
0.1382
0.1021
589


Ex 490
EBL
Dopant 2D-A
Host 2D-A
Ref.
3.62
5.50
0.1382
0.1021
552


Ex 491
EBL
Dopant 2D-A
Host 2D-A
HBL1
3.62
6.88
0.1382
0.1021
920


Ex 492
EBL
Dopant 2D-A
Host 2D-A
HBL2
3.47
8.26
0.1382
0.1011
736


Ex 493
Ref.
Dopant 2D-A
Host 2D-P1
Ref.
3.75
5.13
0.1413
0.1042
250


Ex 494
Ref.
Dopant 2D-A
Host 2D-P1
HBL1
3.75
6.16
0.1413
0.1042
416


Ex 495
Ref.
Dopant 2D-A
Host 2D-P1
HBL2
3.60
6.50
0.1383
0.1022
333


Ex 496
EBL
Dopant 2D-A
Host 2D-P1
Ref.
3.55
5.47
0.1383
0.1022
312


Ex 497
EBL
Dopant 2D-A
Host 2D-P1
HBL1
3.55
6.84
0.1383
0.1022
520


Ex 498
EBL
Dopant 2D-A
Host 2D-P1
HBL2
3.40
8.21
0.1383
0.1012
416


Ex 499
Ref.
Dopant 2D-A
Host 2D-P2
Ref.
3.77
5.14
0.1411
0.1039
251


Ex 500
Ref.
Dopant 2D-A
Host 2D-P2
HBL1
3.77
6.17
0.1411
0.1039
418


Ex 501
Ref.
Dopant 2D-A
Host 2D-P2
HBL2
3.62
6.51
0.1381
0.1019
334


Ex 502
EBL
Dopant 2D-A
Host 2D-P2
Ref.
3.57
5.48
0.1381
0.1019
313


Ex 503
EBL
Dopant 2D-A
Host 2D-P2
HBL1
3.57
6.85
0.1381
0.1019
522


Ex 504
EBL
Dopant 2D-A
Host 2D-P2
HBL2
3.42
8.22
0.1381
0.1009
418









TABLE 31














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ref 37
Ref.
Dopant 2
Host 3
Ref.
3.72
5.01
0.1416
0.1053
162


Ref 38
Ref.
Dopant 2
Host 3
HBL1
3.72
6.01
0.1416
0.1053
270


Ref 39
Ref.
Dopant 2
Host 3
HBL2
3.57
6.35
0.1386
0.1033
216


Ref 40
EBL
Dopant 2
Host 3
Ref.
3.52
5.34
0.1386
0.1033
203


Ref 41
EBL
Dopant 2
Host 3
HBL1
3.52
6.68
0.1386
0.1033
338


Ref 42
EBL
Dopant 2
Host 3
HBL2
3.37
8.02
0.1386
0.1023
270


Ex 505
Ref.
Dopant 2
Host 3D
Ref.
3.73
5.00
0.1411
0.1052
281


Ex 506
Ref.
Dopant 2
Host 3D
HBL1
3.73
5.99
0.1411
0.1052
468


Ex 507
Ref.
Dopant 2
Host 3D
HBL2
3.58
6.33
0.1381
0.1032
374


Ex 508
EBL
Dopant 2
Host 3D
Ref.
3.53
5.33
0.1381
0.1032
351


Ex 509
EBL
Dopant 2
Host 3D
HBL1
3.53
6.66
0.1381
0.1032
585


Ex 510
EBL
Dopant 2
Host 3D
HBL2
3.38
7.99
0.1381
0.1022
468


Ex 511
Ref.
Dopant 2
Host 3D-A
Ref.
3.71
4.99
0.1411
0.1053
288


Ex 512
Ref.
Dopant 2
Host 3D-A
HBL1
3.71
5.99
0.1411
0.1053
479


Ex 513
Ref.
Dopant 2
Host 3D-A
HBL2
3.56
6.32
0.1381
0.1033
383


Ex 514
EBL
Dopant 2
Host 3D-A
Ref.
3.51
5.32
0.1381
0.1033
359


Ex 515
EBL
Dopant 2
Host 3D-A
HBL1
3.51
6.65
0.1381
0.1033
599


Ex 516
EBL
Dopant 2
Host 3D-A
HBL2
3.36
7.98
0.1381
0.1023
479









TABLE 32














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 517
Ref.
Dopant 2
Host 3D-P1
Ref.
3.71
4.96
0.1412
0.1051
162


Ex 518
Ref.
Dopant 2
Host 3D-P1
HBL1
3.71
5.95
0.1412
0.1051
270


Ex 519
Ref.
Dopant 2
Host 3D-P1
HBL2
3.56
6.28
0.1382
0.1031
216


Ex 520
EBL
Dopant 2
Host 3D-P1
Ref.
3.51
5.29
0.1382
0.1031
203


Ex 521
EBL
Dopant 2
Host 3D-P1
HBL1
3.51
6.61
0.1382
0.1031
338


Ex 522
EBL
Dopant 2
Host 3D-P1
HBL2
3.36
7.93
0.1382
0.1021
270


Ex 523
Ref.
Dopant 2
Host 3D-P2
Ref.
3.72
5.01
0.1414
0.1053
162


Ex 524
Ref.
Dopant 2
Host 3D-P2
HBL1
3.72
6.01
0.1414
0.1053
270


Ex 525
Ref.
Dopant 2
Host 3D-P2
HBL2
3.57
6.35
0.1384
0.1033
216


Ex 526
EBL
Dopant 2
Host 3D-P2
Ref.
3.52
5.34
0.1384
0.1033
203


Ex 527
EBL
Dopant 2
Host 3D-P2
HBL1
3.52
6.68
0.1384
0.1033
338


Ex 528
EBL
Dopant 2
Host 3D-P2
HBL2
3.37
8.02
0.1384
0.1023
270


Ex 529
Ref.
Dopant 2D
Host 3
Ref.
3.72
5.00
0.1412
0.1052
198


Ex 530
Ref.
Dopant 2D
Host 3
HBL1
3.72
6.00
0.1412
0.1052
330


Ex 531
Ref.
Dopant 2D
Host 3
HBL2
3.57
6.34
0.1382
0.1032
264


Ex 532
EBL
Dopant 2D
Host 3
Ref.
3.52
5.34
0.1382
0.1032
247


Ex 533
EBL
Dopant 2D
Host 3
HBL1
3.52
6.67
0.1382
0.1032
412


Ex 534
EBL
Dopant 2D
Host 3
HBL2
3.37
8.00
0.1382
0.1022
330









TABLE 33














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 535
Ref.
Dopant 2D
Host 3D
Ref.
3.71
5.02
0.1415
0.1052
354


Ex 536
Ref.
Dopant 2D
Host 3D
HBL1
3.71
6.02
0.1415
0.1052
590


Ex 537
Ref.
Dopant 2D
Host 3D
HBL2
3.56
6.36
0.1385
0.1032
472


Ex 538
EBL
Dopant 2D
Host 3D
Ref.
3.51
5.35
0.1385
0.1032
442


Ex 539
EBL
Dopant 2D
Host 3D
HBL1
3.51
6.69
0.1385
0.1032
737


Ex 540
EBL
Dopant 2D
Host 3D
HBL2
3.36
8.03
0.1385
0.1022
590


Ex 541
Ref.
Dopant 2D
Host 3D-A
Ref.
3.70
5.00
0.1412
0.1049
359


Ex 542
Ref.
Dopant 2D
Host 3D-A
HBL1
3.70
5.99
0.1412
0.1049
598


Ex 543
Ref.
Dopant 2D
Host 3D-A
HBL2
3.55
6.33
0.1382
0.1029
479


Ex 544
EBL
Dopant 2D
Host 3D-A
Ref.
3.50
5.33
0.1382
0.1029
449


Ex 545
EBL
Dopant 2D
Host 3D-A
HBL1
3.50
6.66
0.1382
0.1029
748


Ex 546
EBL
Dopant 2D
Host 3D-A
HBL2
3.35
7.99
0.1382
0.1019
598


Ex 547
Ref.
Dopant 2D
Host 3D-P1
Ref.
3.75
5.01
0.1418
0.1053
197


Ex 548
Ref.
Dopant 2D
Host 3D-P1
HBL1
3.75
6.01
0.1418
0.1053
328


Ex 549
Ref.
Dopant 2D
Host 3D-P1
HBL2
3.60
6.35
0.1388
0.1033
262


Ex 550
EBL
Dopant 2D
Host 3D-P1
Ref.
3.55
5.34
0.1388
0.1033
246


Ex 551
EBL
Dopant 2D
Host 3D-P1
HBL1
3.55
6.68
0.1388
0.1033
410


Ex 552
EBL
Dopant 2D
Host 3D-P1
HBL2
3.40
8.02
0.1388
0.1023
328









TABLE 34














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 553
Ref.
Dopant 2D
Host 3D-P2
Ref.
3.71
4.99
0.1415
0.1051
199


Ex 554
Ref.
Dopant 2D
Host 3D-P2
HBL1
3.71
5.99
0.1415
0.1051
331


Ex 555
Ref.
Dopant 2D
Host 3D-P2
HBL2
3.56
6.32
0.1385
0.1031
265


Ex 556
EBL
Dopant 2D
Host 3D-P2
Ref.
3.51
5.32
0.1385
0.1031
248


Ex 557
EBL
Dopant 2D
Host 3D-P2
HBL1
3.51
6.65
0.1385
0.1031
414


Ex 558
EBL
Dopant 2D
Host 3D-P2
HBL2
3.36
7.98
0.1385
0.1021
331


Ex 559
Ref.
Dopant 2D-A
Host 3
Ref.
3.72
5.02
0.1411
0.1051
219


Ex 560
Ref.
Dopant 2D-A
Host 3
HBL1
3.72
6.02
0.1411
0.1051
365


Ex 561
Ref.
Dopant 2D-A
Host 3
HBL2
3.57
6.36
0.1381
0.1031
292


Ex 562
EBL
Dopant 2D-A
Host 3
Ref.
3.52
5.35
0.1381
0.1031
274


Ex 563
EBL
Dopant 2D-A
Host 3
HBL1
3.52
6.69
0.1381
0.1031
456


Ex 564
EBL
Dopant 2D-A
Host 3
HBL2
3.37
8.03
0.1381
0.1021
365


Ex 565
Ref.
Dopant 2D-A
Host 3D
Ref.
3.71
5.02
0.1414
0.1051
372


Ex 566
Ref.
Dopant 2D-A
Host 3D
HBL1
3.71
6.02
0.1414
0.1051
619


Ex 567
Ref.
Dopant 2D-A
Host 3D
HBL2
3.56
6.36
0.1384
0.1031
495


Ex 568
EBL
Dopant 2D-A
Host 3D
Ref.
3.51
5.35
0.1384
0.1031
464


Ex 569
EBL
Dopant 2D-A
Host 3D
HBL1
3.51
6.69
0.1384
0.1031
774


Ex 570
EBL
Dopant 2D-A
Host 3D
HBL2
3.36
8.03
0.1384
0.1021
619









TABLE 35














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 571
Ref.
Dopant 2D-A
Host 3D-A
Ref.
3.73
5.01
0.1411
0.1052
390


Ex 572
Ref.
Dopant 2D-A
Host 3D-A
HBL1
3.73
6.01
0.1411
0.1052
650


Ex 573
Ref.
Dopant 2D-A
Host 3D-A
HBL2
3.58
6.35
0.1381
0.1032
520


Ex 574
EBL
Dopant 2D-A
Host 3D-A
Ref.
3.53
5.34
0.1381
0.1032
487


Ex 575
EBL
Dopant 2D-A
Host 3D-A
HBL1
3.53
6.68
0.1381
0.1032
812


Ex 576
EBL
Dopant 2D-A
Host 3D-A
HBL2
3.38
8.02
0.1381
0.1022
650


Ex 577
Ref.
Dopant 2D-A
Host 3D-P1
Ref.
3.71
4.97
0.1414
0.1053
218


Ex 578
Ref.
Dopant 2D-A
Host 3D-P1
HBL1
3.71
5.96
0.1414
0.1053
364


Ex 579
Ref.
Dopant 2D-A
Host 3D-P1
HBL2
3.56
6.29
0.1384
0.1033
291


Ex 580
EBL
Dopant 2D-A
Host 3D-P1
Ref.
3.51
5.30
0.1384
0.1033
273


Ex 581
EBL
Dopant 2D-A
Host 3D-P1
HBL1
3.51
6.62
0.1384
0.1033
455


Ex 582
EBL
Dopant 2D-A
Host 3D-P1
HBL2
3.36
7.94
0.1384
0.1023
364


Ex 583
Ref.
Dopant 2D-A
Host 3D-P2
Ref.
3.70
5.00
0.1414
0.1053
219


Ex 584
Ref.
Dopant 2D-A
Host 3D-P2
HBL1
3.70
6.00
0.1414
0.1053
365


Ex 585
Ref.
Dopant 2D-A
Host 3D-P2
HBL2
3.55
6.34
0.1384
0.1033
292


Ex 586
EBL
Dopant 2D-A
Host 3D-P2
Ref.
3.50
5.34
0.1384
0.1033
274


Ex 587
EBL
Dopant 2D-A
Host 3D-P2
HBL1
3.50
6.67
0.1384
0.1033
456


Ex 588
EBL
Dopant 2D-A
Host 3D-P2
HBL2
3.35
8.00
0.1384
0.1023
365









TABLE 36














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ref 43
Ref.
Dopant 2
Host 4
Ref.
3.74
5.03
0.1412
0.1051
168


Ref 44
Ref.
Dopant 2
Host 4
HBL1
3.74
6.03
0.1412
0.1051
281


Ref 45
Ref.
Dopant 2
Host 4
HBL2
3.59
6.37
0.1382
0.1031
225


Ref 46
EBL
Dopant 2
Host 4
Ref.
3.54
5.36
0.1382
0.1031
211


Ref 47
EBL
Dopant 2
Host 4
HBL1
3.54
6.70
0.1382
0.1031
351


Ref 48
EBL
Dopant 2
Host 4
HBL2
3.39
8.04
0.1382
0.1021
281


Ex 589
Ref.
Dopant 2
Host 4D
Ref.
3.74
5.05
0.1411
0.1051
288


Ex 590
Ref.
Dopant 2
Host 4D
HBL1
3.74
6.06
0.1411
0.1051
480


Ex 591
Ref.
Dopant 2
Host 4D
HBL2
3.59
6.39
0.1381
0.1031
384


Ex 592
EBL
Dopant 2
Host 4D
Ref.
3.54
5.38
0.1381
0.1031
360


Ex 593
EBL
Dopant 2
Host 4D
HBL1
3.54
6.73
0.1381
0.1031
600


Ex 594
EBL
Dopant 2
Host 4D
HBL2
3.39
8.08
0.1381
0.1021
480


Ex 595
Ref.
Dopant 2
Host 4D-A
Ref.
3.75
5.02
0.1410
0.1053
293


Ex 596
Ref.
Dopant 2
Host 4D-A
HBL1
3.75
6.02
0.1410
0.1053
488


Ex 597
Ref.
Dopant 2
Host 4D-A
HBL2
3.60
6.36
0.1380
0.1033
390


Ex 598
EBL
Dopant 2
Host 4D-A
Ref.
3.55
5.35
0.1380
0.1033
366


Ex 599
EBL
Dopant 2
Host 4D-A
HBL1
3.55
6.69
0.1380
0.1033
610


Ex 600
EBL
Dopant 2
Host 4D-A
HBL2
3.40
8.03
0.1380
0.1023
488









TABLE 37














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 601
Ref.
Dopant 2
Host 4D-P1
Ref.
3.71
5.01
0.1411
0.1052
168


Ex 602
Ref.
Dopant 2
Host 4D-P1
HBL1
3.71
6.01
0.1411
0.1052
281


Ex 603
Ref.
Dopant 2
Host 4D-P1
HBL2
3.56
6.35
0.1381
0.1032
225


Ex 604
EBL
Dopant 2
Host 4D-P1
Ref.
3.51
5.34
0.1381
0.1032
211


Ex 605
EBL
Dopant 2
Host 4D-P1
HBL1
3.51
6.68
0.1381
0.1032
351


\Ex 606
EBL
Dopant 2
Host 4D-P1
HBL2
3.36
8.02
0.1381
0.1022
281


Ex 607
Ref.
Dopant 2
Host 4D-P2
Ref.
3.70
5.01
0.1415
0.1051
168


Ex 608
Ref.
Dopant 2
Host 4D-P2
HBL1
3.70
6.01
0.1415
0.1051
281


Ex 609
Ref.
Dopant 2
Host 4D-P2
HBL2
3.55
6.35
0.1385
0.1031
225


Ex 610
EBL
Dopant 2
Host 4D-P2
Ref.
3.50
5.34
0.1385
0.1031
211


Ex 611
EBL
Dopant 2
Host 4D-P2
HBL1
3.50
6.68
0.1385
0.1031
351


Ex 612
EBL
Dopant 2
Host 4D-P2
HBL2
3.35
8.02
0.1385
0.1021
281


Ex 613
Ref.
Dopant 2D
Host 4
Ref.
3.73
5.04
0.1417
0.1050
207


Ex 614
Ref.
Dopant 2D
Host 4
HBL1
3.73
6.05
0.1417
0.1050
345


Ex 615
Ref.
Dopant 2D
Host 4
HBL2
3.58
6.38
0.1387
0.1030
276


Ex 616
EBL
Dopant 2D
Host 4
Ref.
3.53
5.38
0.1387
0.1030
259


Ex 617
EBL
Dopant 2D
Host 4
HBL1
3.53
6.72
0.1387
0.1030
431


Ex 618
EBL
Dopant 2D
Host 4
HBL2
3.38
8.06
0.1387
0.1020
345









TABLE 38














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 619
Ref.
Dopant 2D
Host 4D
Ref.
3.73
5.03
0.1413
0.1052
367


Ex 620
Ref.
Dopant 2D
Host 4D
HBL1
3.73
6.03
0.1413
0.1052
611


Ex 621
Ref.
Dopant 2D
Host 4D
HBL2
3.58
6.37
0.1383
0.1032
489


Ex 622
EBL
Dopant 2D
Host 4D
Ref.
3.53
5.36
0.1383
0.1032
458


Ex 623
EBL
Dopant 2D
Host 4D
HBL1
3.53
6.70
0.1383
0.1032
764


Ex 624
EBL
Dopant 2D
Host 4D
HBL2
3.38
8.04
0.1383
0.1022
611


Ex 625
Ref.
Dopant 2D
Host 4D-A
Ref.
3.73
5.04
0.1412
0.1052
379


Ex 626
Ref.
Dopant 2D
Host 4D-A
HBL1
3.73
6.05
0.1412
0.1052
632


Ex 627
Ref.
Dopant 2D
Host 4D-A
HBL2
3.58
6.38
0.1382
0.1032
506


Ex 628
EBL
Dopant 2D
Host 4D-A
Ref.
3.53
5.38
0.1382
0.1032
474


Ex 629
EBL
Dopant 2D
Host 4D-A
HBL1
3.53
6.72
0.1382
0.1032
790


Ex 630
EBL
Dopant 2D
Host 4D-A
HBL2
3.38
8.06
0.1382
0.1022
632


Ex 631
Ref.
Dopant 2D
Host 4D-P1
Ref.
3.72
5.03
0.1408
0.1053
208


Ex 632
Ref.
Dopant 2D
Host 4D-P1
HBL1
3.72
6.04
0.1408
0.1053
346


Ex 633
Ref.
Dopant 2D
Host 4D-P1
HBL2
3.57
6.37
0.1378
0.1033
277


Ex 634
EBL
Dopant 2D
Host 4D-P1
Ref.
3.52
5.37
0.1378
0.1033
260


Ex 635
EBL
Dopant 2D
Host 4D-P1
HBL1
3.52
6.71
0.1378
0.1033
433


Ex 636
EBL
Dopant 2D
Host 4D-P1
HBL2
3.37
8.05
0.1378
0.1023
346









TABLE 39














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 637
Ref.
Dopant 2D
Host 4D-P2
Ref.
3.71
5.03
0.1412
0.1050
209


Ex 638
Ref.
Dopant 2D
Host 4D-P2
HBL1
3.71
6.03
0.1412
0.1050
348


Ex 639
Ref.
Dopant 2D
Host 4D-P2
HBL2
3.56
6.37
0.1382
0.1030
278


Ex 640
EBL
Dopant 2D
Host 4D-P2
Ref.
3.51
5.36
0.1382
0.1030
261


Ex 641
EBL
Dopant 2D
Host 4D-P2
HBL1
3.51
6.70
0.1382
0.1030
435


Ex 642
EBL
Dopant 2D
Host 4D-P2
HBL2
3.36
8.04
0.1382
0.1020
348


Ex 643
Ref.
Dopant 2D-A
Host 4
Ref.
3.74
5.01
0.1413
0.1052
227


Ex 644
Ref.
Dopant 2D-A
Host 4
HBL1
3.74
6.01
0.1413
0.1052
378


Ex 645
Ref.
Dopant 2D-A
Host 4
HBL2
3.59
6.35
0.1383
0.1032
303


Ex 646
EBL
Dopant 2D-A
Host 4
Ref.
3.54
5.34
0.1383
0.1032
284


Ex 647
EBL
Dopant 2D-A
Host 4
HBL1
3.54
6.68
0.1383
0.1032
473


Ex 648
EBL
Dopant 2D-A
Host 4
HBL2
3.39
8.02
0.1383
0.1022
378


Ex 649
Ref.
Dopant 2D-A
Host 4D
Ref.
3.73
5.03
0.1413
0.1052
384


Ex 650
Ref.
Dopant 2D-A
Host 4D
HBL1
3.73
6.04
0.1413
0.1052
640


Ex 651
Ref.
Dopant 2D-A
Host 4D
HBL2
3.58
6.37
0.1383
0.1032
512


Ex 652
EBL
Dopant 2D-A
Host 4D
Ref.
3.53
5.37
0.1383
0.1032
480


Ex 653
EBL
Dopant 2D-A
Host 4D
HBL1
3.53
6.71
0.1383
0.1032
800


Ex 654
EBL
Dopant 2D-A
Host 4D
HBL2
3.38
8.05
0.1383
0.1022
640









TABLE 40














EBL
EML
HBL
V
cd/A
CIE (x, y)
T95 [hr]




Ex 655
Ref.
Dopant 2D-A
Host 4D-A
Ref.
3.71
5.03
0.1411
0.1050
397


Ex 656
Ref.
Dopant 2D-A
Host 4D-A
HBL1
3.71
6.03
0.1411
0.1050
662


Ex 657
Ref.
Dopant 2D-A
Host 4D-A
HBL2
3.56
6.37
0.1381
0.1030
530


Ex 658
EBL
Dopant 2D-A
Host 4D-A
Ref.
3.51
5.36
0.1381
0.1030
497


Ex 659
EBL
Dopant 2D-A
Host 4D-A
HBL1
3.51
6.70
0.1381
0.1030
828


Ex 660
EBL
Dopant 2D-A
Host 4D-A
HBL2
3.36
8.04
0.1381
0.1020
662


Ex 661
Ref.
Dopant 2D-A
Host 4D-P1
Ref.
3.70
5.01
0.1410
0.1053
227


Ex 662
Ref.
Dopant 2D-A
Host 4D-P1
HBL1
3.70
6.01
0.1410
0.1053
378


Ex 663
Ref.
Dopant 2D-A
Host 4D-P1
HBL2
3.55
6.35
0.1380
0.1033
303


Ex 664
EBL
Dopant 2D-A
Host 4D-P1
Ref.
3.50
5.34
0.1380
0.1033
284


Ex 665
EBL
Dopant 2D-A
Host 4D-P1
HBL1
3.50
6.68
0.1380
0.1033
473


Ex 666
EBL
Dopant 2D-A
Host 4D-P1
HBL2
3.35
8.02
0.1380
0.1023
378


Ex 667
Ref.
Dopant 2D-A
Host 4D-P2
Ref.
3.74
5.02
0.1412
0.1051
227


Ex 668
Ref.
Dopant 2D-A
Host 4D-P2
HBL1
3.74
6.02
0.1412
0.1051
378


Ex 669
Ref.
Dopant 2D-A
Host 4D-P2
HBL2
3.59
6.36
0.1382
0.1031
303


Ex 670
EBL
Dopant 2D-A
Host 4D-P2
Ref.
3.54
5.35
0.1382
0.1031
284


Ex 671
EBL
Dopant 2D-A
Host 4D-P2
HBL1
3.54
6.69
0.1382
0.1031
473


Ex 672
EBL
Dopant 2D-A
Host 4D-P2
HBL2
3.39
8.03
0.1382
0.1021
378






As shown in Tables 1 to 40, in comparison to the OLED in Comparative Examples 1 to 48, which uses the non-deuterated anthracene derivative as the host and the non-deuterated pyrene derivative as the dopant, the lifespan of the OLED in Examples 1 to 672, which uses an anthracene derivative as the host and a pyrene derivative as the dopant and at least one of anthracene derivative and the pyrene derivative is deuterated, is increased.


Particularly, when at least one of an anthracene core of the anthracene derivative as the host and a pyrene core of the pyrene derivative as the dopant is deuterated or at least one of the anthracene derivative and the pyrene derivative is wholly deuterated, the lifespan of the OLED is significantly increased.


On the other hand, in comparison to the OLED, which uses the wholly-deuterated anthracene derivative as the host, the lifespan of the OLED, which uses the core-deuterated anthracene derivative as the host, is slightly short. However, the OLED using the core-deuterated anthracene derivative provides sufficient lifespan increase with low ratio of deuterium, which is expensive. Namely, the OLED has enhanced emitting efficiency and lifespan with minimizing production cost increase.


In addition, in comparison to the OLED, which uses the wholly-deuterated pyrene derivative as the host, the lifespan of the OLED, which uses the core-deuterated pyrene derivative as the host, is slightly short. However, the OLED using the core-deuterated pyrene derivative provides sufficient lifespan increase with low ratio of deuterium, which is expensive.


Moreover, the EBL includes the electron blocking material of Formula 8 such that the emitting efficiency and the lifespan of the OLED is further improved.


Further, the HBL includes the hole blocking material of Formula 10 or 12 such that the emitting efficiency and the lifespan of the OLED is further improved.



FIG. 4 is a schematic cross-sectional view illustrating an OLED having a tandem structure of two emitting units according to the first embodiment of the present disclosure.


As shown in FIG. 4, the OLED D includes the first and second electrodes 160 and 164 facing each other and the organic emitting layer 162 between the first and second electrodes 160 and 164. The organic emitting layer 162 includes a first emitting part 310 including a first EML 320, a second emitting part 330 including a second EML 340 and a charge generation layer (CGL) 350 between the first and second emitting parts 310 and 330. Namely, the OLED D in FIG. 4 and the OLED D in FIG. 3 have a difference in the organic emitting layer 162.


The first electrode 160 may be formed of a conductive material having a relatively high work function to serve as an anode for injecting a hole into the organic emitting layer 162. The second electrode 164 may be formed of a conductive material having a relatively low work function to serve as a cathode for injecting an electron into the organic emitting layer 162. The first electrode 160 may be formed of ITO or IZO, and the second electrode 164 may be formed of Al, Mg, Ag, AlMg or MgAg.


The CGL 350 is positioned between the first and second emitting parts 310 and 330, and the first emitting part 310, the CGL 350 and the second emitting part 330 are sequentially stacked on the first electrode 160. Namely, the first emitting part 310 is positioned between the first electrode 160 and the CGL 350, and the second emitting part 330 is positioned between the second electrode 164 and the CGL 350.


The first emitting part 310 includes a first EML 320. In addition, the first emitting part 310 may further include a first EBL 316 between the first electrode 160 and the first EML 320 and a first HBL 318 between the first EML 320 and the CGL 350.


In addition, the first emitting part 310 may further include a first HTL 314 between the first electrode 160 and the first EBL 316 and an HIL 312 between the first electrode 160 and the first HTL 314.


The first EML 320 includes a host 322, which is an anthracene derivative, and a dopant 324, which is a pyrene derivative, and at least one of the hydrogen atoms in the anthracene derivative and the pyrene derivative, is substituted by a deuterium atom (D). The first EML 320 provides a blue emission.


For example, the hydrogen atoms in at least one of the anthracene derivative and the pyrene derivative may be wholly deuterated. When the anthracene derivative as the host 322 is wholly deuterated (e.g., “wholly-deuterated anthracene derivative”), the hydrogen atoms in the pyrene derivative as the dopant 324 may be non-deuterated (e.g., “non-deuterated pyrene derivative”), a part of the hydrogen atoms in the pyrene derivative as the dopant 324 may be deuterated (e.g., “partially-deuterated pyrene derivative”), or all of the hydrogen atoms in the pyrene derivative as the dopant 324 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). Alternatively, when the pyrene derivative as the dopant 324 is wholly deuterated (e.g., “wholly-deuterated pyrene derivative”), the hydrogen atoms in the anthracene derivative as the host 322 may be non-deuterated (e.g., “non-deuterated anthracene derivative”), a part of the hydrogen atoms in the anthracene derivative as the host 322 may be deuterated (e.g., “partially-deuterated anthracene derivative”), or all of the hydrogen atoms in the anthracene derivative as the host 322 may be deuterated (e.g., “wholly-deuterated anthracene derivative”).


At least one of an anthracene core of the host 322 and a pyrene core of the dopant 324 may be deuterated.


For example, when the anthracene core of the host 322 is deuterated (e.g., “core-deuterated anthracene derivative”), the dopant 324 may be non-deuterated (e.g., “non-deuterated pyrene derivative”) or all of the pyrene core and a substituent of the dopant 324 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). Alternatively, the pyrene core of the dopant 324 except the substituent may be deuterated (e.g., “core-deuterated pyrene derivative”), or the substituent of the dopant 324 except the pyrene core may be deuterated (e.g., “substituent-deuterated pyrene derivative”).


On the other hand, in the first EML 320, when the pyrene core of the dopant 324 is deuterated (e.g., “core-deuterated pyrene derivative”), the host 322 may be non-deuterated (e.g., “non-deuterated anthracene derivative”) or all of the anthracene core and a substituent of the host 322 may be deuterated (e.g., “wholly-deuterated anthracene derivative”). Alternatively, the anthracene core of the host 322 except the substituent may be deuterated (e.g., “core-deuterated anthracene derivative”), or the substituent of the host 322 except the anthracene core may be deuterated (e.g., “substituent-deuterated anthracene derivative”).


In the first EML 320, the host 322 may have a weight % of about 70 to 99.9, and the dopant 324 may have a weight % of about 0.1 to 30. To provide sufficient emitting efficiency and lifespan, a weight % of the dopant 324 may be about 0.1 to 10, preferably about 1 to 5.


The first EBL 316 may include the electron blocking material of Formula 8. In addition, the first HBL 318 may include at least one of the hole blocking material of Formula 10 and the hole blocking material of Formula 12.


The second emitting part 330 includes the second EML 340. In addition, the second emitting part 330 may further include a second EBL 334 between the CGL 350 and the second EML 340 and a second HBL 336 between the second EML 340 and the second electrode 164.


In addition, the second emitting part 330 may further include a second HTL 332 between the CGL 350 and the second EBL 334 and an EIL 338 between the second HBL 336 and the second electrode 164.


The second EML 340 includes a host 342, which is an anthracene derivative, a dopant 344, which is a pyrene derivative, and at least one of the hydrogen atoms in the anthracene derivative and the pyrene derivative, is substituted by a deuterium atom (D). The second EML 340 provides a blue emission.


For example, the anthracene derivative as the host 342 may be wholly deuterated (e.g., “wholly-deuterated anthracene derivative”), or the anthracene core of the anthracene derivative may be deuterated (e.g., “core-deuterated anthracene derivative”). In this instance, the hydrogen atoms in the pyrene derivative as the dopant 344 may be non-deuterated (e.g., “non-deuterated pyrene derivative”), or all of the pyrene core and a substituent of the dopant 344 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). Alternatively, the pyrene core of the dopant 344 except the substituent may be deuterated (e.g., “core-deuterated pyrene derivative”), or the substituent of the dopant 344 except the pyrene core may be deuterated (e.g., “substituent-deuterated pyrene derivative”).


The pyrene derivative as the dopant 344 may be wholly deuterated (e.g., “wholly-deuterated pyrene derivative”), or the pyrene core of the pyrene derivative may be deuterated (e.g., “core-deuterated pyrene derivative”). In this instance, the hydrogen atoms in the anthracene derivative as the host 342 may be non-deuterated (e.g., “non-deuterated anthracene derivative”), or all of the anthracene core and a substituent of the host 342 may be deuterated (e.g., “wholly-deuterated anthracene derivative”). Alternatively, the anthracene core of the host 342 except the substituent may be deuterated (e.g., “core-deuterated anthracene derivative”), or the substituent of the host 342 except the anthracene core may be deuterated (e.g., “substituent-deuterated anthracene derivative”).


In the second EML 340, the host 342 may have a weight % of about 70 to 99.9, and the dopant 344 may have a weight % of about 0.1 to 30. To provide sufficient emitting efficiency and lifespan, a weight % of the dopant 344 may be about 0.1 to 10, preferably about 1 to 5.


The host 342 of the second EML 340 may be same as or different from the host 322 of the first EML 320, and the dopant 344 of the second EML 340 may be same as or different from the dopant 324 of the first EML 320.


The second EBL 334 may include the electron blocking material of Formula 8. In addition, the second HBL 336 may include at least one of the hole blocking material of Formula 10 and the hole blocking material of Formula 12.


The CGL 350 is positioned between the first and second emitting parts 310 and 330. Namely, the first and second emitting parts 310 and 330 are connected through the CGL 350. The CGL 350 may be a P-N junction CGL of an N-type CGL 352 and a P-type CGL 354.


The N-type CGL 352 is positioned between the first HBL 318 and the second HTL 332, and the P-type CGL 354 is positioned between the N-type CGL 352 and the second HTL 332.


In the OLED D, since each of the first and second EMLs 320 and 340 includes the host 322 and 342, each of which is an anthracene derivative, and the dopant 324 and 344, each of which is a pyrene derivative, and at least one of the hydrogens in the anthracene derivative and of the pyrene derivative is substituted by D (e.g., deuterated). As a result, the OLED D and the organic light emitting display device 100 have advantages in the emitting efficiency and the lifespan.


For example, when at least one of an anthracene core of the anthracene derivative and a pyrene core of the pyrene derivative is deuterated, the OLED and the organic light emitting display device 100 have sufficient emitting efficiency and lifespan with minimizing production cost increase.


In addition, at least one of the first and second EBLs 316 and 334 includes an amine derivative of Formula 9, and at least one of the first and second HBLs 318 and 336 includes at least one of a hole blocking material of Formula 11 and a hole blocking material of Formula 13. As a result, the lifespan of the OLED D and the organic light emitting display device 100 is further improved.


In addition, since the first and second emitting parts 310 and 330 for emitting blue light are stacked, the organic light emitting display device 100 provides an image having high color temperature.



FIG. 5 is a schematic cross-sectional view illustrating an organic light emitting display device according to a second embodiment of the present disclosure, and FIG. 6 is a schematic cross-sectional view illustrating an OLED for the organic light emitting display device according to the second embodiment of the present disclosure.


As shown in FIG. 5, the organic light emitting display device 400 includes a first substrate 410, where a red pixel RP, a green pixel GP and a blue pixel BP are defined, a second substrate 470 facing the first substrate 410, an OLED D, which is positioned between the first and second substrates 410 and 470 and providing white emission, and a color filter layer 480 between the OLED D and the second substrate 470.


Each of the first and second substrates 410 and 470 may be a glass substrate or a plastic substrate. For example, each of the first and second substrates 410 and 470 may be a polyimide substrate.


A buffer layer 420 is formed on the substrate, and the TFT Tr corresponding to each of the red, green and blue pixels RP, GP and BP is formed on the buffer layer 420. The buffer layer 420 may be omitted.


A semiconductor layer 422 is formed on the buffer layer 420. The semiconductor layer 122 may include an oxide semiconductor material or polycrystalline silicon.


A gate insulating layer 424 is formed on the semiconductor layer 422. The gate insulating layer 424 may be formed of an inorganic insulating material such as silicon oxide or silicon nitride.


A gate electrode 430, which is formed of a conductive material, e.g., metal, is formed on the gate insulating layer 424 to correspond to a center of the semiconductor layer 422.


An interlayer insulating layer 432, which is formed of an insulating material, is formed on the gate electrode 430. The interlayer insulating layer 432 may be formed of an inorganic insulating material, e.g., silicon oxide or silicon nitride, or an organic insulating material, e.g., benzocyclobutene or photo-acryl.


The interlayer insulating layer 432 includes first and second contact holes 434 and 436 exposing both sides of the semiconductor layer 422. The first and second contact holes 434 and 436 are positioned at both sides of the gate electrode 430 to be spaced apart from the gate electrode 430.


A source electrode 440 and a drain electrode 442, which are formed of a conductive material, e.g., metal, are formed on the interlayer insulating layer 432.


The source electrode 440 and the drain electrode 442 are spaced apart from each other with respect to the gate electrode 430 and respectively contact both sides of the semiconductor layer 422 through the first and second contact holes 434 and 436.


The semiconductor layer 422, the gate electrode 430, the source electrode 440 and the drain electrode 442 constitute the TFT Tr. The TFT Tr serves as a driving element. Namely, the TFT Tr may correspond to the driving TFT Td (of FIG. 1).


Although not shown, the gate line and the data line cross each other to define the pixel, and the switching TFT is formed to be connected to the gate and data lines. The switching TFT is connected to the TFT Tr as the driving element.


In addition, the power line, which may be formed to be parallel to and spaced apart from one of the gate and data lines, and the storage capacitor for maintaining the voltage of the gate electrode of the TFT Tr in one frame may be further formed.


A passivation layer 450, which includes a drain contact hole 452 exposing the drain electrode 442 of the TFT Tr, is formed to cover the TFT Tr.


A first electrode 460, which is connected to the drain electrode 442 of the TFT Tr through the drain contact hole 452, is separately formed in each pixel. The first electrode 160 may be an anode and may be formed of a conductive material having a relatively high work function. For example, the first electrode 460 may be formed of a transparent conductive material such as indium-tin-oxide (ITO) or indium-zinc-oxide (IZO).


A reflection electrode or a reflection layer may be formed under the first electrode 460. For example, the reflection electrode or the reflection layer may be formed of aluminum-palladium-copper (APC) alloy.


A bank layer 466 is formed on the passivation layer 450 to cover an edge of the first electrode 460. Namely, the bank layer 466 is positioned at a boundary of the pixel and exposes a center of the first electrode 460 in the red, green and blue pixels RP, GP and BP. The bank layer 466 may be omitted.


An organic emitting layer 462 is formed on the first electrode 460.


Referring to FIG. 6, the organic emitting layer 462 includes a first emitting part 530 including a first EML 520, a second emitting part 550 including a second EML 540, a third emitting part 570 including a third EML 560, a first CGL 580 between the first and second emitting parts 530 and 550 and a second CGL 590 between the second and third emitting parts 550 and 570.


The first electrode 460 may be formed of a conductive material having a relatively high work function to serve as an anode for injecting a hole into the organic emitting layer 462. The second electrode 464 may be formed of a conductive material having a relatively low work function to serve as a cathode for injecting an electron into the organic emitting layer 462. The first electrode 460 may be formed of ITO or IZO, and the second electrode 464 may be formed of Al, Mg, Ag, AlMg or MgAg.


The first CGL 580 is positioned between the first and second emitting parts 530 and 550, and the second CGL 590 is positioned between the second and third emitting parts 550 and 570. Namely, the first emitting part 530, the first CGL 580, the second emitting part 550, the second CGL 590 and the third emitting part 570 are sequentially stacked on the first electrode 460. In other words, the first emitting part 530 is positioned between the first electrode 460 and the first CGL 570, the second emitting part 550 is positioned between the first and second CGLs 580 and 590, and the third emitting part 570 is positioned between the second electrode 460 and the second CGL 590.


The first emitting part 530 may include an HIL 532, a first HTL 534, a first EBL 536, the first EML 520 and a first HBL 538 sequentially stacked on the first electrode 460. Namely, the HIL 532, the first HTL 534 and the first EBL 536 are positioned between the first electrode 460 and the first EML 520, and the first HBL 538 is positioned between the first EML 520 and the first CGL 580.


The first EML 520 includes a host 522, which is an anthracene derivative, and a dopant 524, which is a pyrene derivative, and at least one of the hydrogen atoms in the anthracene derivative and the pyrene derivative, is substituted by a deuterium atom (D). The first EML 520 provides a blue emission.


For example, the hydrogen atoms in at least one of the anthracene derivative and the pyrene derivative may be wholly deuterated. When the anthracene derivative as the host 522 is wholly deuterated (e.g., “wholly-deuterated anthracene derivative”), the hydrogen atoms in the pyrene derivative as the dopant 524 may be non-deuterated (e.g., “non-deuterated pyrene derivative”), a part of the hydrogen atoms in the pyrene derivative as the dopant 524 may be deuterated (e.g., “partially-deuterated pyrene derivative”), or all of the hydrogen atoms in the pyrene derivative as the dopant 524 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). Alternatively, when the pyrene derivative as the dopant 524 is wholly deuterated (e.g., “wholly-deuterated pyrene derivative”), the hydrogen atoms in the anthracene derivative as the host 522 may be non-deuterated (e.g., “non-deuterated anthracene derivative”), a part of the hydrogen atoms in the anthracene derivative as the host 522 may be deuterated (e.g., “partially-deuterated anthracene derivative”), or all of the hydrogen atoms in the anthracene derivative as the host 522 may be deuterated (e.g., “wholly-deuterated anthracene derivative”).


At least one of an anthracene core of the host 522 and a pyrene core of the dopant 524 may be deuterated.


For example, when the anthracene core of the host 522 is deuterated (e.g., “core-deuterated anthracene derivative”), the dopant 524 may be non-deuterated (e.g., “non-deuterated pyrene derivative”) or all of the pyrene core and a substituent of the dopant 524 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). Alternatively, the pyrene core of the dopant 524 except the substituent may be deuterated (e.g., “core-deuterated pyrene derivative”), or the substituent of the dopant 524 except the pyrene core may be deuterated (e.g., “substituent-deuterated pyrene derivative”).


On the other hand, in the first EML 520, when the pyrene core of the dopant 524 is deuterated (e.g., “core-deuterated pyrene derivative”), the host 522 may be non-deuterated (e.g., “non-deuterated anthracene derivative”) or all of the anthracene core and a substituent of the host 522 may be deuterated (e.g., “wholly-deuterated anthracene derivative”). Alternatively, the anthracene core of the host 522 except the substituent may be deuterated (e.g., “core-deuterated anthracene derivative”), or the substituent of the host 522 except the anthracene core may be deuterated (e.g., “substituent-deuterated anthracene derivative”).


In the first EML 520, the host 522 may have a weight % of about 70 to 99.9, and the dopant 524 may have a weight % of about 0.1 to 30. To provide sufficient emitting efficiency and lifespan, a weight % of the dopant 524 may be about 0.1 to 10, preferably about 1 to 5.


The first EBL 536 may include the electron blocking material of Formula 8. In addition, the first HBL 538 may include at least one of the hole blocking material of Formula 10 and the hole blocking material of Formula 12.


The second EML 550 may include a second HTL 552, the second EML 540 and an electron transporting layer (ETL) 554. The second HTL 552 is positioned between the first CGL 580 and the second EML 540, and the ETL 554 is positioned between the second EML 540 and the second CGL 590.


The second EML 540 may be a yellow-green EML. For example, the second EML 540 may include a host and a yellow-green dopant. Alternatively, the second EML 540 may include a host, a red dopant and a green dopant. In this instance, the second EML 540 may include a lower layer including the host and the red dopant (or the green dopant) and an upper layer including the host and the green dopant (or the red dopant).


The third emitting part 570 may include a third HTL 572, a second EBL 574, the third EML 560, a second HBL 576 and an EIL 578.


The third EML 560 includes a host 562, which is an anthracene derivative, a dopant 564, which is a pyrene derivative, and at least one of the hydrogen atoms in the anthracene derivative and the pyrene derivative, is substituted by a deuterium atom (D). The third EML 560 provides a blue emission.


For example, in the third EML 560, the anthracene derivative as the host 562 may be wholly deuterated (e.g., “wholly-deuterated anthracene derivative”), or the anthracene core of the anthracene derivative may be deuterated (e.g., “core-deuterated anthracene derivative”). In this instance, the hydrogen atoms in the pyrene derivative as the dopant 564 may be non-deuterated (e.g., “non-deuterated pyrene derivative”), or all of the pyrene core and a substituent of the dopant 564 may be deuterated (e.g., “wholly-deuterated pyrene derivative”). Alternatively, the pyrene core of the dopant 564 except the substituent may be deuterated (e.g., “core-deuterated pyrene derivative”), or the substituent of the dopant 564 except the pyrene core may be deuterated (e.g., “substituent-deuterated pyrene derivative”).


The pyrene derivative as the dopant 564 may be wholly deuterated (e.g., “wholly-deuterated pyrene derivative”), or the pyrene core of the pyrene derivative may be deuterated (e.g., “core-deuterated pyrene derivative”). In this instance, the hydrogen atoms in the anthracene derivative as the host 562 may be non-deuterated (e.g., “non-deuterated anthracene derivative”), or all of the anthracene core and a substituent of the host 562 may be deuterated (e.g., “wholly-deuterated anthracene derivative”). Alternatively, the anthracene core of the host 562 except the substituent may be deuterated (e.g., “core-deuterated anthracene derivative”), or the substituent of the host 562 except the anthracene core may be deuterated (e.g., “substituent-deuterated anthracene derivative”).


In the third EML 560, the host 562 may have a weight % of about 70 to 99.9, and the dopant 564 may have a weight % of about 0.1 to 30. To provide sufficient emitting efficiency and lifespan, a weight % of the dopant 564 may be about 0.1 to 10, preferably about 1 to 5.


The host 562 of the third EML 560 may be same as or different from the host 522 of the first EML 520, and the dopant 564 of the third EML 560 may be same as or different from the dopant 524 of the first EML 520.


The second EBL 574 may include the electron blocking material of Formula 8. In addition, the second HBL 576 may include at least one of the hole blocking material of Formula 10 and the hole blocking material of Formula 12. The electron blocking material in the second EBL 574 and the electron blocking material in the first EBL 536 may be same or different, and the hole blocking material in the second HBL 576 and the hole blocking material in the first HBL 538 may be same or different.


The first CGL 580 is positioned between the first emitting part 530 and the second emitting part 550, and the second CGL 590 is positioned between the second emitting part 550 and the third emitting part 570. Namely, the first and second emitting stacks 530 and 550 are connected through the first CGL 580, and the second and third emitting stacks 550 and 570 are connected through the second CGL 590. The first CGL 580 may be a P-N junction CGL of a first N-type CGL 582 and a first P-type CGL 584, and the second CGL 590 may be a P-N junction CGL of a second N-type CGL 592 and a second P-type CGL 594.


In the first CGL 580, the first N-type CGL 582 is positioned between the first HBL 538 and the second HTL 552, and the first P-type CGL 584 is positioned between the first N-type CGL 582 and the second HTL 552.


In the second CGL 590, the second N-type CGL 592 is positioned between the ETL 554 and the third HTL 572, and the second P-type CGL 594 is positioned between the second N-type CGL 592 and the third HTL 572.


In the OLED D, each of the first and third EMLs 520 and 560 includes the host 522 and 562, each of which is an anthracene derivative, the blue dopant 524 and 564, each of which is a pyrene derivative.


Accordingly, the OLED D including the first and third emitting parts 530 and 570 with the second emitting part 550, which emits yellow-green light or red/green light, can emit white light.


In FIG. 6, the OLED D has a triple-stack structure of the first, second and third emitting parts 530, 550 and 570. Alternatively, the OLED D may have a double-stack structure without the first emitting part 530 or the third emitting part 570.


Referring to FIG. 5 again, a second electrode 464 is formed over the substrate 410 where the organic emitting layer 462 is formed.


In the organic light emitting display device 400, since the light emitted from the organic emitting layer 462 is incident to the color filter layer 480 through the second electrode 464, the second electrode 464 has a thin profile for transmitting the light.


The first electrode 460, the organic emitting layer 462 and the second electrode 464 constitute the OLED D.


The color filter layer 480 is positioned over the OLED D and includes a red color filter 482, a green color filter 484 and a blue color filter 486 respectively corresponding to the red, green and blue pixels RP, GP and BP.


Although not shown, the color filter layer 480 may be attached to the OLED D by using an adhesive layer. Alternatively, the color filter layer 480 may be formed directly on the OLED D.


An encapsulation film (not shown) may be formed to prevent penetration of moisture into the OLED D. For example, the encapsulation film may include a first inorganic insulating layer, an organic insulating layer and a second inorganic insulating layer sequentially stacked, but it is not limited thereto. The encapsulation film may be omitted.


A polarization plate (not shown) for reducing an ambient light reflection may be disposed over the top-emission type OLED D. For example, the polarization plate may be a circular polarization plate.


In FIG. 5, the light from the OLED D passes through the second electrode 464, and the color filter layer 480 is disposed on or over the OLED D. Alternatively, when the light from the OLED D passes through the first electrode 460, the color filter layer 480 may be disposed between the OLED D and the first substrate 410.


A color conversion layer (not shown) may be formed between the OLED D and the color filter layer 480. The color conversion layer may include a red color conversion layer, a green color conversion layer and a blue color conversion layer respectively corresponding to the red, green and blue pixels RP, GP and BP. The white light from the OLED D is converted into the red light, the green light and the blue light by the red, green and blue color conversion layer, respectively.


As described above, the white light from the organic light emitting diode D passes through the red color filter 482, the green color filter 484 and the blue color filter 486 in the red pixel RP, the green pixel GP and the blue pixel BP such that the red light, the green light and the blue light are provided from the red pixel RP, the green pixel GP and the blue pixel BP, respectively.


In FIGS. 5 and 6, the OLED D emitting the white light is used for a display device. Alternatively, the OLED D may be formed on an entire surface of a substrate without at least one of the driving element and the color filter layer to be used for a lightening device. The display device and the lightening device each including the OLED D of the present disclosure may be referred to as an organic light emitting device.



FIG. 7 is a schematic cross-sectional view illustrating an organic light emitting display device according to a third embodiment of the present disclosure.


As shown in FIG. 7, the organic light emitting display device 600 includes a first substrate 610, where a red pixel RP, a green pixel GP and a blue pixel BP are defined, a second substrate 670 facing the first substrate 610, an OLED D, which is positioned between the first and second substrates 610 and 670 and providing white emission, and a color conversion layer 680 between the OLED D and the second substrate 670.


Although not shown, a color filter may be formed between the second substrate 670 and each color conversion layer 680.


A TFT Tr, which corresponding to each of the red, green and blue pixels RP, GP and BP, is formed on the first substrate 610, and a passivation layer 650, which has a drain contact hole 652 exposing an electrode, e.g., a drain electrode, of the TFT Tr is formed to cover the TFT Tr.


The OLED D including a first electrode 660, an organic emitting layer 662 and a second electrode 664 is formed on the passivation layer 650. In this instance, the first electrode 660 may be connected to the drain electrode of the TFT Tr through the drain contact hole 652.


A bank layer 666 covering an edge of the first electrode 660 is formed at a boundary of the red, green and blue pixel regions RP, GP and BP.


The OLED D emits a blue light and may have a structure shown in FIG. 3 or FIG. 4. Namely, the OLED D is formed in each of the red, green and blue pixels RP, GP and BP and provides the blue light.


The color conversion layer 680 includes a first color conversion layer 682 corresponding to the red pixel RP and a second color conversion layer 684 corresponding to the green pixel GP. For example, the color conversion layer 680 may include an inorganic color conversion material such as a quantum dot.


The blue light from the OLED D is converted into the red light by the first color conversion layer 682 in the red pixel RP, and the blue light from the OLED D is converted into the green light by the second color conversion layer 684 in the green pixel GP.


Accordingly, the organic light emitting display device 600 can display a full-color image.


On the other hand, when the light from the OLED D passes through the first substrate 610, the color conversion layer 680 is disposed between the OLED D and the first substrate 610.


While the present disclosure has been described with reference to exemplary embodiments and examples, these embodiments and examples are not intended to limit the scope of the present disclosure. Rather, it will be apparent to those skilled in the art that various modifications and variations can be made in the present disclosure without departing from the spirit or scope of the invention. Thus, it is intended that the present disclosure cover the modifications and variations of the present disclosure provided they come within the scope of the appended claims and their equivalents.


The various embodiments described above can be combined to provide further embodiments. All of patents, patent application publications, patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in the Application Data Sheet are incorporated herein by reference, in their entirety. Aspects of the embodiments can be modified, if necessary to employ concepts of the various patents, applications and publications to provide yet further embodiments.


These and other changes can be made to the embodiments in light of the above-detailed description. In general, in the following claims, the terms used should not be construed to limit the claims to the specific embodiments disclosed in the specification and the claims, but should be construed to include all possible embodiments along with the full scope of equivalents to which such claims are entitled. Accordingly, the claims are not limited by the disclosure.

Claims
  • 1. An organic light emitting diode (OLED), comprising: a first electrode;a second electrode facing the first electrode;a first emitting material layer including a first host being an anthracene derivative and a first dopant being a pyrene derivative and positioned between the first and second electrodes; anda first electron blocking layer including an electron blocking material of a spirofluorene-substituted amine derivative and positioned between the first electrode and the first emitting material layer,wherein at least one of hydrogen atoms in the anthracene derivative and the pyrene derivative is deuterated.
  • 2. The OLED of claim 1, wherein all of the hydrogen atoms in at least one of the anthracene derivative and the pyrene derivative are deuterated.
  • 3. The OLED of claim 1, wherein at least one of an anthracene core of the anthracene derivative and a pyrene core of the pyrene derivative is deuterated.
  • 4. The OLED of claim 3, wherein the anthracene derivative is represented by Formula 1: wherien each of R1 and R2 is independently C6∼C30 aryl group or C5∼C30 heteroaryl group, and each of L1, L2, L3 and L4 is independently C6∼C30 arylene group, andwherein each of a, b, c and d is 0 or 1, and e is an integer of 1 to 8.
  • 5. The OLED of claim 4, wherein the anthracene derivative is a compound being one of the followings of Formula 2: .
  • 6. The OLED of one of claims 3, wherein the pyrene derivative is represented by Formula 3: wherein each of X1 and X2 is independently O or S, each of Ar1 and Ar2 is independently C6∼C30 aryl group or C5∼C3o heteroaryl group,wherein R3 is C1∼C10 alkyl group or C1∼C10 cycloalkyl group, and f is an integer of 1 to 8, andwherein g is an integer of 0 to 2, and a summation of f and g is 8 or less.
  • 7. The OLED of claim 6, wherein the pyrene derivative is a compound being one of the followings of Formula 4: .
  • 8. The OLED of claim 1, wherein the electron blocking material is represented by Formula 5: wherein L is arylene group, and a is 0 or 1, andwherein each of R1 and R2 is independently selected from the group consisting of C6 to C30 arylene group and C5 to C30 heteroarylene group.
  • 9. The OLED of claim 8, wherein the electron blocking material is a compound being one of the followings of Formula 6: Formula 6 .
  • 10. The OLED of claim 1, further comprising: a first hole blocking layer including at least one of a first hole blocking material being an azine derivative and a second hole blocking material being a benzimidazole derivative and positioned between the second electrode and the first emitting material layer.
  • 11. The OLED of claim 10, wherein the first hole blocking material is represented by Formula 7: Formula 7 wherein each of Y1 to Y5 are independently CR1 or N, and one to three of Y1 to Y5 is N,wherein R1 is independently hydrogen or C6∼C30 aryl group,wherein L is C6∼C30 arylene group, and R2 is C6∼C30 aryl group or C5∼C3o hetero aryl group,wherein R3 is hydrogen, or adjacent two of R3 form a fused ring, andwherein “a” is 0 or 1, “b” is 1 or 2, and “c” is an integer of 0 to 4.
  • 12. The OLED of claim 11, wherein the first hole blocking material is a compound being one of the followings of Formula 8: Formula 8 .
  • 13. The OLED of claim 10, wherein the second hole blocking material is represented by Formula 9: wherein Ar is C10∼C3o arylene group, R1 is C6∼C30 aryl group or C5∼C3o hetero aryl group, andwherein R2 is C1∼C10 alkyl group or C6∼C30 aryl group.
  • 14. The OLED of claim 13, wherein the second hole blocking material is a compound being one of the followings of Formula 10: Formula 10 .
  • 15. The OLED of claim 1, further comprising: a second emitting material layer including a second host being an anthracene derivative and a second dopant being a pyrene derivative and positioned between the first emitting material layer and the second electrode; anda first charge generation layer between the first and second emitting material layers,wherein at least one of hydrogen atoms in the second host and the second dopant is deuterated.
  • 16. The OLED of claim 15, further comprising: a third emitting material layer emitting a yellow-green light and positioned between the first charge generation layer and the second emitting material layer; anda second charge generation layer between the second and third emitting material layers.
  • 17. The OLED of claim 15, further comprising: a third emitting material layer emitting a red light and a green light and positioned between the first charge generation layer and the second emitting material layer; anda second charge generation layer between the second and third emitting material layers.
  • 18. An organic light emitting device, comprising: a substrate;an organic light emitting diode positioned on the substrate and including a first electrode; a second electrode facing the first electrode; a first emitting material layer including a first host being an anthracene derivative and a first dopant being a pyrene derivative and positioned between the first and second electrodes; and a first electron blocking layer including an electron blocking material of a spirofluorene-substituted amine derivative and positioned between the first electrode and the first emitting material layer,wherein at least one of hydrogen atoms in the anthracene derivative and the pyrene derivative is deuterated.
  • 19. The organic light emitting device of claim 18, wherein all of the hydrogen atoms in at least one of the anthracene derivative and the pyrene derivative are deuterated.
  • 20. The organic light emitting device of claim 18, wherein at least one of an anthracene core of the anthracene derivative and a pyrene core of the pyrene derivative is deuterated.
  • 21. The organic light emitting device of claim 20, wherein the anthracene derivative is represented by Formula 1: wherien each of R1 and R2 is independently C6∼C30 aryl group or C5∼C30 heteroaryl group, and each of L1, L2, L3 and L4 is independently C6∼C30 arylene group, andwherein each of a, b, c and d is 0 or 1, and e is an integer of 1 to 8.
  • 22. The organic light emitting device of claim 21, wherein the anthracene derivative is a compound being one of the followings of Formula 2: .
  • 23. The organic light emitting device of claim 20, wherein the pyrene derivative is represented by Formula 3: wherein each of X1 and X2 is independently O or S, each of Ar1 and Ar2 is independently C6∼C30 aryl group or C5∼C3o heteroaryl group,wherein R3 is C1~C10 alkyl group or C1~C10 cycloalkyl group, and f is an integer of 1 to 8, andwherein g is an integer of 0 to 2, and a summation of f and g is 8 or less.
  • 24. The organic light emitting device of claim 23, wherein the pyrene derivative is a compound being one of the followings of Formula 4: .
  • 25. The organic light emitting device of claim 18, wherein the electron blocking material is represented by Formula 5: wherein L is arylene group, and a is 0 or 1, andwherein each of R1 and R2 is independently selected from the group consisting of C6 to C30 arylene group and C5 to C30 heteroarylene group.
  • 26. The organic light emitting device of claim 25, wherein the electron blocking material is a compound being one of the followings of Formula 6: .
  • 27. The organic light emitting device of claim 18, further comprising: a first hole blocking layer including at least one of a first hole blocking material being an azine derivative and a second hole blocking material being a benzimidazole derivative and positioned between the second electrode and the first emitting material layer.
  • 28. The organic light emitting device of claim 27, wherein the first hole blocking material is represented by Formula 7: wherein each of Y1 to Y5 are independently CR1 or N, and one to three of Y1 to Y5 is N,wherein R1 is independently hydrogen or C6∼C30 aryl group,wherein L is C6∼C30 arylene group, and R2 is C6∼C30 aryl group or C5-C30 hetero aryl group,wherein R3 is hydrogen, or adjacent two of R3 form a fused ring, andwherein “a” is 0 or 1, “b” is 1 or 2, and “c” is an integer of 0 to 4.
  • 29. The organic light emitting device of claim 28, wherein the first hole blocking material is a compound being one of the followings of Formula 8: Formula 8 .
  • 30. The organic light emitting device of claim 27, wherein the second hole blocking material is represented by Formula 9: wherein Ar is C10∼C30 arylene group, R1 is C6∼C30 aryl group or C5∼C30 hetero aryl group, andwherein R2 is C1~C10 alkyl group or C6∼C30 aryl group.
  • 31. The organic light emitting device of claim 30, wherein the second hole blocking material is a compound being one of the followings of Formula 10: .
  • 32. The organic light emitting device of claim 18, wherein the organic light emitting diode further includes: a second emitting material layer including a second host being an anthracene derivative and a second dopant being a pyrene derivative and positioned between the first emitting material layer and the second electrode; anda first charge generation layer between the first and second emitting material layers,wherein at least one of hydrogen atoms in the second host and the second dopant is deuterated.
  • 33. The organic light emitting device of claims 18, wherein a red pixel, a green pixel and a blue pixel are defined on the substrate, and the organic light emitting diode corresponds to each of the red, green and blue pixels, and wherein the organic light emitting device further includes: a color conversion layer disposed between the substrate and the organic light emitting diode or on the organic light emitting diode and corresponding to the red and green pixels.
  • 34. The organic light emitting device of claim 32, wherein the organic light emitting diode further includes: a third emitting material layer emitting a yellow-green light and positioned between the first charge generation layer and the second emitting material layer; anda second charge generation layer between the second and third emitting material layers.
  • 35. The organic light emitting device of claim 32, wherein the organic light emitting diode further includes: a third emitting material layer emitting a red light and a green light and positioned between the first charge generation layer and the second emitting material layer; anda second charge generation layer between the second and third emitting material layers.
  • 36. The organic light emitting device of claim 34, wherein a red pixel, a green pixel and a blue pixel are defined on the substrate, and the organic light emitting diode corresponds to each of the red, green and blue pixels, and wherein the organic light emitting device further includes: a color filter layer disposed between the substrate and the organic light emitting diode or on the organic light emitting diode and corresponding to the red, green and blue pixels.
Priority Claims (1)
Number Date Country Kind
10-2019-0178652 Dec 2019 KR national
PCT Information
Filing Document Filing Date Country Kind
PCT/KR2020/018957 12/23/2020 WO